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SUMMARY♦
Ricin is isolated from the plant Ricinus communis, and is an 
extremely toxic protein. The protein consists of two functionally 
distinct polypeptides, ricin A chain which will inhibit protein synthesis 
in eucaryotic cells, and the ricin B chain which acts as a lectin binding 
to galactose-containing cell surface macromolecules. Ricin has been 
extensively studied in attempt to determine both the biochemical and 
physical properties of the protein.
Ricin has been attributed with anti-tumorogenic properties, and 
has recently been used in the synthesis of immunotoxins.
Studies on the interactions of immunotoxin molecules have indicated that 
the ricin B polypeptide may not function simply as a lectin. When cells 
were treated with a weakly toxic dose of an antibody - ricin A conjugate, 
the cytotoxicity was less than that of an antibody - ricin conjugate.
The cytotoxicity of the antibody - ricin A conjugate can be greatly 
enhanced by the addition to the culture system of either free ricin B 
polypeptide or an antibody - ricin B complex. Thus it would appear that 
the ricin B chain was responsible for promoting access of the ricin A 
chain into the cytosol. It is this putative transport function of the 
ricin B chain that this project sought to address.
Before the principle experimental investigation could be undertaken 
a method for the purification of the commercially produced ricin B chain 
had to be developed, for it was found to contain ricin holotoxin. This 
was achieved by chromatofocusing for the isoelectric point of ricin is
7.1 and ricin B chain is 4.8, and this difference allowed separation. 
Affinity chromatography using Sepharose 4B pretreated with 1.0M propionic 
acid, as the column matrix, was utilised to separate the polybuffer 
(chromatofocusing buffer) from the purified ricin B chain. This also had 
the added advantage of confirming that the ricin B polypeptide retained
its ability to function as a lectin. The purity of the ricin B chain was 
ascertained by silver staining of SDS-PAGE gels and cytotoxicity assays.
To study the 'hypothetical' transport function of the ricin B 
polypeptide, a complex was synthesised between bovine pancreatic RNase A 
and ricin B chain. Bovine pancreatic RNase A was chosen for a number of 
reasons, the main one being the possibility of determining the 
internalisation of the RNase A by the ricin B chain due to the enzymatic
digestion of cellular RNA which could be measured by a decrease in
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incorporation of [ S]-methionine or ( H]-thymidine by the cell
cultures. The heterobifunctional cross-linking reagent, SPDP, was chosen
to link the RNase A molecule to the ricin B polypeptide, so that a
disulphide bridge was formed between the two proteins. This duplicates
the disulphide linkage normally found between the ricin A and ricin B
chains. The formation of the RNase A - ricin B complex was determined by
silver staining of SDS-PAGE gels. The putative complex had a Mr of
45,000, indicating a complex containing equimolar amounts of RNase A and
ricin B chain. Immunoblotting experiments confirmed that the 45kD species
visualised on SDS-PAGE contained antigenic determinants derived from both
RNase A and ricin B chain molecules. Two dimensional gel electrophoresis
of iodinated RNase A - ricin B complex confirmed the formation of the
complex as well as showing that the complex was basic having an
isoelectric point in the range pH 8.0-8.5.
The RNase A - ricin B complex had to retain the functional activity 
of both the proteins, so that its effect on Daudi cells in culture could 
be examined. The enzymatic activity of the RNase A present in the RNase 
A - ricin B complex was assessed using activity gels. Areas of enzymatic 
digestion of the yeast RNA present in the activity gel were visualised as 
clear plaques. Iodination of RNase A then linkage of this to the ricin B 
polypeptide showed that the ricin B chain was binding to
galactose-containing molecules on the cell surface. Unfortunately, when 
the effects of the RNase A - ricin B complex w&tt examined on cells in 
culture, no effect on DNA or protein synthesis due to the enzymatic 
action of RNase A was observed.
The results therefore confirmed earlier work which showed that 
insulin - ricin B conjugate, bound to galactose containing receptors 
present on the cell surface. The question of the internalisation of the 
chimeric protein was not answered, although it is known that hybrid 
proteins formed between abrin A -ricin B or gelonin - ricin B are toxic to 
cells which could reflect a synergistic mode of action of the toxic 
molecule and the lectin molecule from plants.
IN T R O D U C T I O N
1. INTRODUCTION.
1.1 GENERAL INTRODUCTION.
There is a strong historical relationship between the seeds of 
Ricinus communis (castor bean) and medicine. Castor beans have been 
utilised in the treatment of a wide variety of diseases as described 
in classical Greek medicine, folk medicine, and in the Susruta 
Ayurveta, a Sanskrit work from the sixth century B.C. Paul Ehrlich 
(1891, 1892) using the plant toxin, ricin, isolated from castor beans, 
carried out extensive studies which resulted in the discovery of some 
of the fundamental principles of immunology. He showed that 
immunisation resulted in the formation of serum proteins capable of 
specifically precipitating and neutralising the toxins, that 
immuno-specificity was associated with the antiserum, and that 
immunity could be transferred to a foetus via the mother's blood 
during pregnancy. Furthermore, it was demonstrated that after the 
birth specific immunity could be passively transferred to the neonate 
via the breast milk.
The severe toxic effects of ricin are historically 
well-documented. A recent, well-publicised example was provided by 
the murder of the Bulgarian radio reporter Georgi Markov by the 
injection of ricin via a modified umbrella tip. The debilitating 
effects of ricin are dependent upon the means of administration, with 
parenteral injection producing the most serious symptoms (Olsnes and 
Pihl, 1976; Olsnes and Sandvig, 1983; Rauber and Heard, 1985). The 
symptoms are nausea, vomiting, pain in the stomach, colic, diarrhoea, 
hemorrhage from the anus, anuria, cramps, dilation of the pupillae, 
fever, thirst, burning in the throat, headache and shock symptoms. 
Death occurs in exhaustion or cramp. The autopsy findings are usually 
multiple ulcera in the stomach and the small intestine, and numerous
hemorrhages around these ulcera (Abdulkadir-Lutfi 1935; Dirheimer,et 
al.t 1966; Guggisberg, 1968). Although the toxin is lethal to all 
individual cell types, the precise organ which sustains the damage 
leading to death is unknown.
1.2. PLANT TOXINS.
Abrin, modeccin, viscumin, volkensin and ricin are isolated from 
plants. Abrin is isolated from the seeds of Abrus precatorius 
(Olsnes and Pihl, 1976). Modeccin and volkensin are found in highest 
concentration in the roots of Adenia digitata and Adenia volkensii 
(Refsnes, et al., 1977; Stirpe et al., 1978; Barbieri, et al., 1984) 
respectively, whilst viscumin is found in all parts of the Viscum 
ft1bum (Olsnes and Sandvig, 1985). These toxins, like ricin, are all 
glycoproteins consisting of two polypeptide chains linked by a 
disulphide bond (Table 1). Each peptide chain mediates a distinct 
biological activity. The A chain possesses an enzymatic activity and 
the B chain has lectin properties binding to carbohydrates with 
terminal galactose residues (Olsnes and Sandvig, 1985).
1.3. RICIN.
Structurally, ricin consists of two functionally distinct 
N-glycosylated polypeptide chains (ricin A and ricin B) linked by a 
single disulphide bond. The ricin A subunit acts by enzymatically 
inactivating the 60S ribosomal subunits, thereby irreversibly 
inhibiting eucaryotic cellular protein synthesis (Sperti, et al.,
1973; Olsnes, et al., 1974; Hedblom, et al., 1976). The other 
subunit, ricin B chain, possesses two galactose binding sites 
(Baenziger and Fiete, 1979) and is therefore thought to function 
principally as a lectin, binding to the galactose or 
N-acetylgalactosamine residues present on the cell surface
TABLE 1.
Biochemical properties of plant toxins and their subunits.
Toxin Mr Plant
Ricin 62,000 Ricinus Communis.
AL  32,000 ”
Af. 30,625 "
B 31,432 "
Abrin 65,000 Abrus Precatorius.
A 30,000 "
B 35,000 "
Modeccin 63,000 Adenia digitata.
A 28,000 "
B 38,000 "
Viscumin 57,000 Viscum album.
A 29,000 "
B 33,000 "
Volkensin 62,000 Adenia volkensii.
( 36,000 "
Subunits (
( 29,000 "
macromolecules. The carbohydrate chains present on the subunits may 
also provide a means by which ricin can bind to cells since animal 
cells have receptors for carbohydrates i.e. mannose - receptors 
present on reticuloendothelial cells (Thorpe, et al., 1985; Skilleter, 
et al., 1985; Skilleter and Foxwell, 1986).
The precise sequence of events involved in ricin intoxication of 
the cell have not yet been elucidated, but it is known that one 
molecule of ricin is sufficient to kill the cell (Eiklid, et al.,
1980). This illustrated the enzymatic nature of ricin action.
Studies have centred on the galactose - receptor mediated endocytotic 
pathway which, for experimental purposes, has been divided into four 
separate steps; binding to the cell surface, endocytotic uptake, 
entry into the cytosol, and inactivation of the intracellular target, 
the ribosomes (Olsnes, et al., 1985).
1.3.1. BINDING TO SURFACE MACROMOLECULES.
Ricin binds to oligosaccharides possessing terminal galactose
residues which are attached to a variety of glycoproteins and
glycolipids present on the cell surface. Ricin binding, as well as
its toxic effect to intact cells, can be inhibited by lactose,
galactose and glycoproteins with terminal galactose residues,
presumably because of their competition with cellular receptors for
ricin. The affinity of binding of ricin to its receptor varies with
the cell type but falls within the range Ka “ 10^ - 1 0 ^  M *
(Olsnes and Pihl, 1982; Olsnes and Sandvig, 1983). Binding is 
o
reversible at 0 C, but at higher temperatures endocytosis of the 
toxin causes irreversible binding of some of the toxin molecules 
(Sandvig and Olsnes, 1979). The number of receptors also differs 
between cell types and it is unclear whether all receptors promote the 
transfer of toxin to the cytosol (Olsnes and Sandvig, 1985).
1.3.2. ENDOCYTOSIS AND DIACYTOSIS.
Ricin bound to cell-surface receptors is internalised by
endocytosis via the coated pit/coated vesicle pathway (Gonatas, et
al., 1980; van Deurs, et al., 1985). Coated pits with bound ricin
mediate its internalisation into coated vesicles. Shortly after
entering the cell the coated vesicles lose their clathrin coats and
the toxin becomes associated with the endosomes (smooth-surfaced
vesicles and tubular structures). Following transit in the vacuolar
portion of the endosomal system, ricin may recycle back to the cell
surface via the tubulo-vesicular portion of the endosomal system and /
or trans Golgi reticulum, pass to the cytosol, or be transferred to
lysosomes (Olsnes and Sandvig, 1985). Diacytosis of ricin (Sandvig,
et al., 1978; Sandvig and Olsnes, 1979) follows completely different
kinetics from those of endocytosis, for there is an abrupt increase in
the release rate at around 20°C and the rate of release approaches
o
its maximum at about 30 C. The trans Golgi reticulum is thought to 
be involved given that ricin is found to accumulate there and movement 
to and from this organelle is inhibited at 20°C (Sandvig and Olsnes, 
1979). However, exocytosis of the toxin occurs by two processes, one 
of which is rapid, the other much slower, therefore indicating the 
existence of two possible routes (Sandvig and Olsnes, 1979). Very 
little ricin appears to accumulate in the lysosomes and it is degraded 
very slowly (Sandvig, et al., 1978a).
Endocytotic uptake of ricin has been followed by linking it to 
horse-radish peroxidase (Gonatas, et al., 1975, 1977), colloidal gold, 
(van Deurs, et al♦, 1985, 1986) and ferritin (Nicolson, 1974;
Nicolson, et al., 1975, 1977). The complexes were bound to the cell 
surface at 4°C, as this temperature arrests endocytosis; the 
temperature was then increased to 37°C, and at various time intervals 
the cells were fixed, sectioned and examined by electron microscopy.
Nevertheless, there are problems associated with these studies, for 
the initial exposure of the cells to a temperature of 4°C may have a 
det irimental physiological effect. The properties of the complexes 
themselves may influence the intracellular routing. It has been 
suggested that it is not the molecules themselves, but the valency of 
the ligand or ligand-conjugate which determines the routing and 
sorting events at the level of the endosomal system (van Deurs, et 
al♦. 1986). This would account for differences in the results of 
Nicolson, et al., (1974, 1975, 1978), Gonatas, et al., (1975, 1977), 
and van Deurs, et al., (1985, 1986).
1.3.3. CYTOSOLIC ENTRY.
The subcellular site of cleavage of the disulphide bond and 
transfer of the enzymatically active A chain into the cytosol has not 
been definitively located. Endocytosed ricin appears to be able to 
enter the cytosol for many hours after uptake (Sandvig and Olsnes, 
1982b). Transfer could occur from the endosome, phagolysosome or the 
Golgi complex. Evidence in favour of the Golgi apparatus is provided 
by experiments in which the temperature was lowered to 20°C. This 
blocked the transport of ricin from the endosome to the Golgi complex 
and inhibited its toxic effect (van Deurs, et al., 1987; Sandvig, et 
al., 1987a). Morphological changes induced in the Golgi by addition 
of a number of inhibitors of glycoprotein synthesis such as 
cycloheximide, tunicamycin, and swainsonine as well as compounds such 
as ammonium chloride, chloroquine and methylamine sensitise cells to 
ricin (Sandvig, et al., 1987a). It should be noted that a neutral or 
slightly alkaline pH is required for ricin toxicity (Sandvig and 
Olsnes, 1982b). Thus, ammonium chloride, chloroquine or methlyamine 
could exert their effect by their ability to increase the pH in acidic 
vesicles, or they could protect ricin from lysosomal degradation (Ray
and Wu, 1981; Sandvig and Olsnes, 1982b; Mekada, et al., 1981). The
calcium ion has also been found to be required for transfer of ricin
to the cytoplasm for the removal of calcium ions with EGTA ,
2+
replacement with Co or the presence of calcium transport inhibitors 
prevent the expression of a toxic effect whilst not effecting binding 
or endocytic uptake (Sandvig and Olsnes, 1982a).
The free A chain enzymatically inactivates the 60S ribosomal 
subunit without the requirement of a cofactor such that protein 
synthesis is abolished (Olsnes and Pihl, 1982). Experimental 
investigations have led to the suggestions that ricin A chain has a 
ribonuclease activity (Obrig, et al., 1985) or that it acts in a 
hydrolytic fashion cleaving the N-glycosidic bond of adenine residue 
4324 in 28S ribosomal RNA (Endo, et al., 1987; Endo and Tsurugi,
1987).
There are indications that ricin can enter the cell by an 
alternative pathway distinct from the receptor mediated endocytic 
pathway (Moya, et al., 1985). Thus, when the coated pit/coated 
vesicle pathway was blocked by a method involving hypotonic shock and 
subsequent K+-depletion or by acidification of the cytosol (Sandvig, 
et al., 1987b), the overall uptake of ricin was only reduced slightly.
Evidence is increasing that the mannose containing 
oligosaccharides on the A and B chains of ricin are recognised by the 
reticuloendothelial system in the liver (non-parenchymal cells; 
mainly Kupffer and sinusoidal endothelial cells) and spleen, 
macrophages, and fibroblasts (Youle, et al., 1979, 1981; Skilleter, et 
al. 1981; Simmons, et al., 1986). It was first shown using 
monophosphopentamannose ricin, that it could be efficiently 
internalised via the mannose receptor and exert a toxic effect (Youle, 
et al., 1979, 1981). Subsequent studies examined ricin uptake 
mediated exclusively via the mannose - terminating oligosaccharide
side chains and mannose receptor. Endocytosis of ricin mediated by 
mannose binding-receptors appears to differ from that seen after 
binding to galactose, a much more extensively studied system.
Simmons, et al., (1986) showed that ammonium chloride, which 
potentiated the toxicity of ricin when endocytosed via the binding of 
the B chain, protected the macrophages when ricin was bound via the 
mannose receptor, thus suggesting the requirement for translocation 
through an acidified compartment for exertion of the toxic effect.
In conclusion, there appears to be a variety of mechanisms by 
which ricin can be internalised by the cell, but the intracellular 
release of the A chain, its enzymatic activity and its interplay with 
the B chains are vital factors which still need to be determined.
1.4. BIOSYNTHESIS OF RICIN.
Ricin is synthesised by endosperm cells, and stored in protein 
bodies for the utilisation of the developing castor bean seedling on 
germination (Tulley and Beevers, 1976; Youle and Huang, 1976). The 
castor bean genome apparently contains six ricin like genes (Hailing, 
et al., 1985). It has been suggested that all members of this 
multigene family may all be transcribed and translated, with the 
products being several ricin-like proteins (Hailing, et al., 1985). 
This is consistent with previous data reported by Cawley, et al., 
(1978) who found they could isolate three forms of ricin.
Transcription and translation processes have been studied to elucidate 
the synthetic pathway of the ricin glycoprotein.
The nucleotide sequence of cloned DNA complementary to ricin 
precursor mRNA has been determined (Butterworth and Lord, 1983; Lamb, 
et al., 1985). The data indicated that the ricin precursor contains 
567 amino acids corresponding to; a 24 amino acid N-terminal leader 
sequence (a putative signal peptide), 267 amino acids comprising the A 
chain, a 12 amino acid linker sequence, and 262 amino acids comprising 
the B chain. The sequencing data confirmed the amino acid analysis of
ricin (Yoshitake, et al., 1978), but there was a major difference at 
amino acid residue 26 of the A chain. Sequencing data predicted an 
asparagine residue as a potential site for asparagine linked 
glycosylation whilst the data of Yoshitake, et al., (1978) indicated 
that an aspartate residue was present. This anomaly has been 
explained by the isolation of the variant or 'heavy' form of ricin A 
chain which contains two N-linked oligosaccharide chains (Foxwell, et 
al., 1985). Hailing, et al., (1985) have also sequenced DNA encoding 
a ricin gene and they found ten nucleotide differences between the 
cDNA sequence reported by Lamb, et al., (1985) as well as suggesting 
that the leader sequence may consist of thirty-five amino acids. 
Furthermore, it has been proposed that many of these differences arise 
from real variations between different genes in the family (Hailing, 
et al., 1985).
The ricin precursor polypeptide is synthesised on membrane bound 
polysomes and segregated into the lumen of the endoplasmic reticulum 
(Lord, 1985). Formation of the disulphide bond linking the individual 
subunits of the mature heterodimer is thought to occur during 
synthesis or segregation, (Bergman and Kuehl, 1979; Roden, et al♦, 
1982). The disulphide linkage is formed between the cysteine residue 
located at the ninth position from the C-termini|S of the ricin A chain 
(cys-259) with the cysteine residue at the fourth position from the 
N-terminu§ of ricin B chain, i.e. cys-4 (Funatsu, et al., 1979). The 
precursor form is extensively modified in the lumen of the endoplasmic 
reticulum. The N-terminal leader sequence is removed, and 
oligosaccharide chains are added (Lord, 1985). Tunicamycin treatment 
of the endosperm tissue inhibited glycosylation of the precursor. 
However, this did not effect the intracellular transport of the toxin 
from the endoplasmic reticulum to the protein bodies (Lord, 1985).
Studies of the intracellular transport mechanism have shown that 
a dense vesicle fraction is involved, and that the oligosaccharide 
moieties of the precursors undergo further modification (Lord, 1985). 
This was ascertained using the enzyme endoglucosaminidase H, which 
deglycosylates the precursor isolated from the endoplasmic reticulum, 
but has no effect on the "more mature" form from the dense vesicle 
fraction. Fucosylation of the oligosaccharide chains is one of the 
modification steps and, by analogy with animal and viral 
glycoproteins, this would indicate that the precursor passed via the 
Golgi apparatus en route to the dense vesicle fraction (Munro, et al., 
1975).
The twelve amino acid linker sequence present in the precursor is 
cleaved by an endoproteinase whilst in the process of transfer to or 
while present in the protein bodies (Harley and Lord, 1985).
It has been hypothesised that the gene for ricin was developed by 
fusion of a gene for ribosome-inactivating proteins with a lectin 
gene. Ribosome-inactivating proteins, are structurally and 
functionally closely related to the ricin A chain (Xuejun and Jiahuai, 
1986; Ready, et al., 1984; Jimenez and Vazquez, 1985). They are 
present in the majority of plants which have been studied for this 
type of protein including, for example, pokeweed, wheat germ, Croton 
tlglium, Jatropha curcas and Gelonium multiflorum, whilst lectins are 
extremely common in plants (Brown and Hunt, 1978).
1.5. RICIN A CHAIN.
The ricin A chain has been found to inhibit protein synthesis by 
inactivating the 60S ribosomal subunit, (Sperti, et al., 1973; Benson, 
et al., 1975). This was demonstrated by separate treatment of the 40S 
and 60S ribosomal subunits with ricin A chain. Treated and untreated 
subunits were mixed in different combinations and their effect on 
polyphenylalanine synthesis determined. Highly purified ricin A chain 
inactivates salt-washed ribosomes in simple buffer solutions at a rate 
of about 1500 ribosomes per minute per ricin A chain. The Km with 
respect to ribosomes is about 2 x 10  ^M, which ensures that ricin A
chain acts in the cytosol at close to its maximal rate, (Olsnes, et
al., 1975). Bacterial ribosomes, and mitochondrial ribsomes are 
resistant to ricin A chain (Olsnes, et al., 1973; Greco, et al.,
1974).
Carrasco, et al., (1975) reported that ricin inhibits the 
enzymatic binding of aminoacyl tRNA to ribosomes, but other groups 
were unable to demonstrate this effect (Montanaro, et al., 1973;
Nolan, et al., 1976). It has also been suggested that the ricin A 
chain acts at the elongation factor binding site(s) on the ribosome. 
Thus, in the presence of excess elongation factor 2 and GTP, under 
which conditions the elongation factor is bound, the ribosomes were 
partially protected against the action of the A chain
(Fernandez-Puentes, et al., 1976). Conversely, A chain treated
ribosomes had lost their ability to bind elongation factor 2 in a GTP 
dependent manner (Carrasc^ et al.. 1975; Nolan, et al., 1976). The A 
chain also inhibited the ribosome dependent elongation factor 2 linked 
hydrolysis of GTP (Montanaro, et al., 1973).
Benson, et al., (1975) released an 8S complex from the 60S 
ribosomal subunits by treatment with EDTA. The 8S complex consisted
of 5S RNA and a single ribosomal protein. The complex was shown to 
have some GTPase activity, (Grummt, et al., 1974). Inhibition of the 
GTPase activity occurs on treatment with ricin A chain.
Studies of polysome profiles have been carried out using cell 
free protein synthesising systems, cells in culture, and animals. 
Olsnes and Pihl, (1972) examined the effect of ricin on the polysome 
profile of a cell-free protein synthesising system. The polysome 
structure appeared to be preserved. Grollman, et al., (1974) showed 
that in Hela cells incubated with ricin, protein synthesis stopped 
after approximately one hour and, concomitantly, that there was 
disaggregation of the polysome structure with the appearance of 
monosomes instead. Polysome break down was also observed in rats 
during the course of ricin intoxication (Lin, et al., 1972). A similar 
result was obtained in ricin-intoxicated mouse myeloma cells, the 
polysomes again disaggregated, but it was felt that this alone was not 
great enough to account for the inhibition of protein synthesis 
(Onozaki, et al., 1975). Lin, et.al., (1972) had shown that there was 
an increase in RNAse activity in the supernatant fraction of rat liver 
cells on intoxication by the plant protein abrin, and assumed ricin 
would have a similar effect. The increase in the enzymatic activity 
of the ribonuclease coincided in time with the disaggregation of 
polyribosomes. Other groups were, however, unable to reproduce this 
effect (Grollman, et al., 1974; Onozaki, et al., 1975). However, 
treatment of 5S or 5.8S rRNA substrates with ricin A chains generated 
distinctive digestion patterns suggesting the existence of a 
ribonuclease activity associated with ricin A chain (Obrig, et al., 
1985). However, Paleologue, et al. (1986) were unable to detect any 
ribonuclease activity associated with the ricin A chain and, indeed, 
their results suggested that it induced only a limited conformational 
change in the 60S subunit, which affected non-covalent associations 
between ribosomal proteins and rRNA.
Experiments by Endo and colleagues (Endo, et al. , 1987) have 
shown that in 28S rRNA isolated from ricin-treated ribosomes, the 
adenine is missing from position 4324 although the phosphoribose 
backbone remains intact. The loss of the base ' . renders the
phosphodiester bond between guanine residue 4323 and adenine residue 
4324 nuclease-resistant, whereas the equivalent linkages on both sides 
of the adenine become hypersensitive to cleavage by alkali and by 
aniline at low pH. Ricin removes approximately one adenine residue 
per ribosome, indicating that the enzymatic cleavage of the 
N-glycosidic bond of adenine 4324 by hydrolysis is the sole site of 
its action. It has been found that the 60S subunits are extremely 
sensitive; the 28S rRNA is also modified although at a reduced rate. 
However, denatured 28S rRNA is resistant to the putative N-glycanase 
activity of the ricin A chain, thus indicating that the A chain 
recognises the three-dimensional structure around adenine 4324. 
Additional evidence supporting this conclusion comes from the finding 
that the target sequence AGUACGAGAGGAAC has been conserved between 
eucaryotes and procaryotes, yet procaryotic ribosomes are resistant to 
the enzymatic activity of the ricin A chain, suggesting that primary 
sequence alone is not sufficient for ricin A chain activity (Olsnes, 
et al., 1973; Greco, et al., 1974).
Modification of arginine residues in the N-terminal part of the 
molecule strongly reduced the inhibitory activity of ricin A chain in 
a cell free protein synthesising system (Watanabe and Funatsu, 1986). 
It is therefore postulated that these residues may ^involved in the 
enzymatic reaction. By analogy with other enzymes, which act on 
negatively charged substrates, arginine residues have been implicated 
in their active sites. Thus, in the case of ricin A chain, it is 
possible that this site interacts with the RNA in the 60S subunit.
The A chain of ricin is not enzymatically active, unless it is
released from the B chain. It is therefore very likely to undergo a
conformational change which activates the enzymatic function. This mery
also expose some of the continuous sequences of hydrophobic amino
acids which occur along ricin A chain, (Funatsu, et al., 1978), and
these hydrophobic region(s) could be crucially involved in
transmembrane interactions leading to the release of ricin A chain
into the cytosol. Treatment of ricin with 2-mercaptoethanol strongly
increased its binding to liposomes (Beugnier, et al., 1982). Ischida,
et al., (1983) studied the interaction of ricin and its subunits with
Newcastle disease virus containing a photoreacbive glycolipid. The
photolabelling experiment showed that the ricin A chain would
spontaneously insert into the viral membrane. Utsuml, et al., (1984)
using liposomes prepared from dipalmitoylphosphatidylcholine showed
that ricin A chain penetrated into the lipid bilayer and destabilised
their organisation.
The X-ray crystallographic structure of ricin A chain at 2.8-A
resolution has been determined (Montfort, et al., 1987). It has been
found to be a globular protein consisting of three domains. The
putative active site cleft is created at the interface between all
three domains. Ricin A chain is heterogeneous containing two
components of molecular weight 30,000 and 32,000 kilodaltons^ a differenc
due only to a difference in carbohydrate units. The lighter component
has been designated the A^ chain and the heavier component the A^
chain (Foxwell, et al., 1985). Characterisation of the A^
carbohydrate side chain has shown it to contain (GlcNAc)^(Xyl) (Fuc)
(Man), „ (Olsnes and Pihl, 1976; Foxwell, et al., 1985). It 
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therefore lacks the trimannosidic core for which concanavalin A has 
high affinity, so it has been termed A chain con A(-). The A^ chain 
contains an extra simple mannose-rich oligosaccharide unit, which 
enables concanavalin A to bind, and is therefore termed con A(+), 
although there does appear to be some heterogenity within this
carbohydrate unit. The carbohydrate chains can be removed by 04- 
mannosidase digestion and deglycosylated ricin A chain retains the 
ability to inactivate ribosomes in a cell-free protein synthesising 
system (Foxwell, et al., 1987). Ricin formed from deglycosylated 
ricin A chain was toxic to AKR-A cells and CBA mice. E. coll cells 
transformed with a plasmid which contains DNA encoding ricin A chain, 
express ricin A chain which is not glycosylated (O'Hare, et al., 
1987). The purified, recombinant ricin A is a potent inhibitor of 
eucaryotic ribosomes, both in the rabbit reticulocyte lysate system 
and in cultured cells. The removal of the carbohydrate chains is 
therefore important when ricin A chain is being used therapeutically, 
for their presence renders ricin more susceptible to clearance by the 
reticuloendothelial system, as shown by the intoxication of mannose 
receptor bearing cells, macrophages, by highly purified ricin A chain 
(Simmons, et al., 1986).
1.6. RICIN B CHAIN.
Ricin B chain, molecular weight 34,700 daltons, (including
the oligosaccharide side chains) possesses two sugar binding domains, 
which bind two galactose residues in a non-co-operative manner (Zentz 
et al., 1978; Houston and Dooley, 1982). Tyrosine-248 has been 
implicated in the 'strong' galactose binding site (Mise, et al., 1986 
Wawrzynczak, et al., 1987) and tryptophan-37 is believed to be 
important in the weak binding site (Hatakeyma, et al., 1986; Rutenber 
et al., 1987). The mode of galactose binding is nearly identical at 
the two sites, the lactose lying in a shallow pocket (see figure la). 
One side of the pocket being formed by the aromatic ring of a side 
group (of Trp-37 in domain 1 and Tyr-248 in domain 2), whilst the 
other side is formed by a slight kink in the chain, involving a
highly-conserved Asp-Val-Arg tripeptide sequence. In domain 1, the 
galactose forms hydrogen bonds to Asn-46 and to Lys-40. These bonds 
involve hydroxyls 3 and 4 of the sugar and help determine the epimeric 
specificity of the binding site. Hydrogen bonding between Asn-46 and 
Asp-22, maintains the position of Asn-46 which is the key residue (see 
Figure lb). In domain 2, Asn-255 is crucial to epimeric specificity, 
binding to hydroxyl 4 of galactose. The position of Asn-255 is
stabilised by a hydrogen bond with Asp 234. A water molecule, bound
to Asn-255, forms a hydrogen bond to hydroxyl 3 of the galactose and 
the water is in a position analogous to Lys-40 of domain 1, Figure lc 
(Rutenber, et al., 1987; Montfort, et al., 1987).
Study of the amino acid sequence of the B chain indicated that it
could be divided into two homologous domains (Villafranca and 
Robertus, 1981). This was confirmed by X-ray crystallography, which 
showed that the B chain did indeed fold into two separate globular 
domains with identical folding topologies, but that the lactose sugars 
were bound at non-homologous sites in the two domains. This result 
can be explained by an analysis of the primary and tertiary structure 
of the B chain which reveals that each of the homologous domains can 
be divided into four peptides, termed A, c< t and
The individual units have undergone considerable divergence, but 
the similarities have been found to be statistically significant. The 
X peptide of domain 1 is homologous to the X peptide of domain 2, but 
these are not related to the other peptides °^ , and ^ , which are 
all homologous with each other. It has therefore been hypothesised 
that the ancestor of the modern B chain was a galactose binding 
peptide which resembled the 1 subdomain which is the only unit which 
retains all the key structural and functional features. Gene 
duplication and fusion then produced the °tp>'^-molecule similar to the 
modern B chain domain. The jS subdomains could then become specialised
Figure 1. The Three Dimensional Structure of Ricin at 2.8&.
a. Ribbon representation of the ricin backbone. The A chain is 
in the upper right of the figure and the B chain at lower left.
The two lactose moieties bound to the B chain are each represented 
as pairs of discs. The disulphide bond linking the chains is 
indicated in the lower right of the molecule.
b. Stereographic view of the lactose binding site in domain 1. 
The lactose molecule has 'open bonds' whereas the protein residues 
are black.
c. Stereographic view of the lactose binding site in domain 2.
(From Montfort, et al. , 1987)
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for a structural role, whilst the ** and would still bind the 
sugars. Fusion of the peptide would then further stabilise the 
structure. Another duplication would then give rise to the 
configuration. Thus, duplication probably blocked galactose access to 
two of the subdomains, causing the present day B chain to bind only 
two saccharide units.
Studies of the toxicity of immunotoxins, hybrid molecules 
consisting of an antibody component of defined fine specificity 
coupled to a potent cytotoxic agent, have led to the finding that 
ricin-containing immunotoxins have greater toxicity than immunotoxins 
containing only the ricin A chain. This has led to the hypothesis 
that ricin B chain may facilitate the translocation of ricin A chain 
into the cytosol, in addition to its receptor binding function. It 
has been demonstrated that the addition of free ricin B chain or B 
chain coupled to an antibody will potentiate the cytotoxicity of ricin 
A chain immunotoxins (Youle and Neville, 1982; McIntosh, et al., 1983;
Vitetta, et al., 1983, 1984). This synergy apparently occurs even 
with ricin B chain antibody complexes in which the B chain has been 
chemically-modified to attenuate its capacity both to bind to cells 
and to form a disulphide bond with the A chain (Cushley, personal 
communication). However data does indicate that lectin activity may 
be essential for the A chain enhancing function of the ricin B chain. 
Youle and Colombatti, (1987) using a cell line which secreted a 
monoclonal antibody which bound specifically to the ricin B chain, 
showed that this antibody was capable of blocking ricin toxicity 
within the cell. This indicates that ricin galactose-binding sites 
are required intracellularly for toxicity. It also showed that these 
receptors exist in the intracellular compartment containing secretory
proteins (putatively the Golgi apparatus which contains more ricin 
binding sites than any other cellular compartment (Yokoyama, et al., 
1980). This may now be settled using site directed mutagenesis of the 
ricin B chain which has been successfully cloned and expressed in 
C0S-M6 cells by Chang, et al., (1987).
Ricin B chain has two oligosaccharide chains consisting of
mannose and N-acetyl glucosamine (one of saccharide composition
(GlcNAc) (Man) , and the other (GlcNAc) (Man)_) attached to 
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asparagine residues at position 93 and 133 of the peptide chain 
(Funatsu, et al., 1979). The influence of these carbohydrate chains 
on the intoxication procedure has been studied. Pure ricin B chain 
has been enzymatically deglycosylated using o<-mannosidase or 
endoglycosidase H (Foxwell, et al., 1985, 1987), and intact ricin was 
treated with sodium metaperiodate at low pH to oxidise the 
carbohydrate chains (Simmons, et al., 1986). Periodate treated ricin 
and intact ricin were compared in toxicity assays on L929 cells, and 
it was found that the toxicity of periodate treated ricin was two 
orders of magnitude lower than that of intact ricin (Simmons, et al., 
1986). This effect could not be explained by a decrease in the 
ability of the B chain to bind to its receptors, or to be a change in 
the binding affinity or to an alteration in the enzymatic activity of 
the ricin A chain. It therefore appeared to be attributable to the 
removal of the oligosaccharide side-chains (Simmons, et al.,1986).
The effect was confirmed by the enzymatic deglycosylation of ricin B 
chain by o<. — mannosidase (Foxwell, et al. , 1985, 1987).
Recombination of ^-mannosidase-treated B chain with ** ~ 
mannosidase-treated A chain led to reduced cytoxicity in vitro. 
However deglycosylation of ricin B chain using endoglycosidase H 
(Foxwell, et al., 1985, 1987) which is only able to cleave one of the 
oligosaccharide side chains due to the protection of the other by the
polypeptide structure, when recombined with deglycosylated ricin A 
chain was exceedingly toxic in vitro. This suggests that the terminal 
mannose residues are required to maintain the conformation of the B 
chain or of intact toxin, and their removal may reduce the ability of 
the B chain to assist the A-chain across the cell membrane to the 
cytosol, or could render it more susceptible to cleavage by cellular 
thiols or proteolytic enzymes (Foxwell, et al., 1987). The final 
destination of the ricin B chain within the cell is still 
undetermined.
There are many continuous sequences of hydrophobic amino acids 
along the ricin B chain, especially at the C-terminus (Funatsu, et al.., 
1979). It has been shown that ricin B chain will insert into the 
membrane of Newcastle disease virus (Ischida et al., 1983).
Experiments which investigated the association of ricin with the lipid 
bilayer of GM^-liposomes at acidic pH demonstrated that for a 
hydrophobic interaction to occur, the binding must be mediated by 
binding of ricin to GM^-liposomes containing galactose moieties 
(Utsurai, et al., 1987). However, the membrane interaction and its 
function in the release of ricin A chain into the cytosol have Still 
to be clarified.
Ricin B chain has been used in the synthesis of a number of 
chimeric molecules, since it was hypothesised that the B chain may be 
able to mediate the translocation of attached molecules to an 
intracellular site appropriate to expression of their biological 
activity. Insulin, abrin A chain and gelonin have all been linked to 
ricin B chain. The insulin - ricin B conjugate was shown to bind to 
receptors for ricin, and that cellular responses due to insulin were 
observed (Roth, et al., 1981; Hofmann, et al.,1983). The location of 
insulin or ricin B chain within the cytoplasm was not ascertained.
The conjugates of abrin A - ricin B chain (Olsnes, et al., 1974b) and 
gelonin - ricin B chain (Goldmacher, et al., 1987), were toxic to 
cells in culture. Gelonin, a ribosome-inactivating protein isolated 
from Geloniim multiflorilTl «. and abrin A chain both inactivate the 60S 
ribosomal subunit, and it could therefore be argued that it is an 
inherent property of these toxic molecules isolated from plants which 
allows interaction with the ricin B chain such that it facilitates 
their entry into the cytosol.
1.7. ROLE OF THE DISULPHIDE BOND.
The disulphide bond that links the A and B moieties of ricin is 
also a property common to most toxins, e.g. dipi^heria toxin, shigella 
toxin, cholera toxin, E. coli heat-liable toxin, abrin, modeccin and 
viscumin. It has been suggested that the disulphide bond does not 
simply prevent dissociation of the A and B chains, for there are 
sufficient weak interactions present to keep them together, mediated 
mainly by the side-chains of prolines and phenylalanines (Montfort, et 
al., 1987), but that it is necessary for toxicity. Lewis and Youle 
(1986) studied the toxicity of reduced ricin and found that the
reduced subunits associated only by non-covalent bonds and were more
toxic to the cell than disulphide bonded subunits. This was in 
contradiction to the findings of Lappi, et al., (1978) which stated 
that associated reduced ricin was less toxic than native ricin. This 
difference can be explained in terms of the concentrations of
associated and native ricin used for at l-100ng per ml the equilibrium
constants would favour complete dissociation of the subunits rendering 
them non-toxic.
It has also been proposed that the disulphide bond may play a 
role in toxin entry. This has been tested experimentally by the 
synthesis of immunotoxins held together by covalent linkages other
than a disulphide bridge (Jansen, et al., 1982; Masuho, et al., 1982). 
When ricin A chain was linked via a thioether bond to an antibody 
against trinitrophenol, no toxic effect was expressed towards 
TNP-derivatised target cells, whereas a similar hybrid containing a 
disulphide bridge was highly toxic (Jansen, et al., 1982). Similar 
experiments were performed using hybrids consisting of ricin A chain 
linked to either F(ab)’  ^or F(ab) fragments of IgG antibodies 
specific to L1210 cells (Masuho, et al., 1982). These workers found 
that when the link was not a disulphide bond the conjugates were
100 times less toxic than when a disulphide bond was employed. Wright 
and Robertus, (1987) alkylated the cysteine residues which link the A 
and B chains of ricin with iodoacetamide. It was found that the 
alkylated ricin would still bind to HeLa cells and alkylated A chain 
was toxic to ribosomes in an in vitro protein synthesis assay.
However, the alkylated molecule showed little or no cytotoxicity 
towards cells in culture suggesting that a functional interdomain 
disulphide bridge is essential probably for transmembrane transport 
(Wright and Robertus, 1987).
It is not known when reduction of the disulphide bond occurs, but 
if reducing agents are not present in the system, then even high 
concentrations of toxin will not inactivate ribosomes. Reduction 
could occur at the cell surface due to transient interactions with 
sulphydryl groups on the membrane during the entry. However, the 
enzyme glutathione protein disulphide oxidoreductase, present in the 
vesicular compartments, can efficiently reduce the interchain 
disulphide bond (Barbieri, et al., 1982). Reduction of intracellular
inhibition of protein synthesis by ricin, whereas ribosome 
inactivation by reduced associated ricin was accelerated. This 
indicates that the reduction of the disulphide bond is probably a rate
glutathione concentrations with
limiting step in the intoxication process (Lewis and Youle, 1986).
Inhibition of protein synthesis does not appear to require free 
thiol groups, for the inhibiting effects of reduced toxins or isolated 
ricin A chain was only moderately lowered after treatment with 
N-ethylmaleimide which binds irreversibly to thiol groups (Olsnes, et 
al., 1975).
1.8. DETERMINATION OF THE EXISTENCE OF A 'TRANSPORT1 FUNCTION OF RICIN 
B CHAIN.
Observations from the interactions of immunotoxin molecules have 
indicated that the ricin B polypeptide has functions other than simple 
ligand binding. Thus in a system where target cells were treated with 
a weakly-toxic dose of an antibody-ricin A chain conjugate, the 
cytotoxicity expressed by that immunotoxin can be greatly enhanced by 
addition to the culture system of either free ricin B polypeptide or 
an antibody - ricin B complex (Vitetta, et al., 1983, 1984). This 
synergy appeared to occur even when the ricin B chain had been 
chemically modified so that it was no longer capable of binding to 
cells or forming a disulphide bond with the ricin A polypeptide 
(Cushley, personal communication). The conclusion drawn from this 
data was that the ricin B polypeptide was responsible for promoting 
the access of the ricin A chain into the cytosol and hence potentiates 
the cytotoxic effect.
The 'hypothetical' transport function of the ricin B polypeptide 
could therefore be used to target reagents (chemicals, enzymes, or 
antibodies) .which do not possess the ability to reach the cytosol 
themselves, a means of gaining access to it. The main objectives of 
this work was to synthesise a complex between ricin B polypeptide and 
ribonuclease A; establish that the two polypeptides of the complex 
retained their biological function! purification of the complex and
development of a cell assay system so that the enzymatic effects of 
the ribonuclease A could be observed in vitro and therefore provide 
evidence that the ricin B polypeptide was capable of internalising 
molecules.
M A T E R I A L S  AND M E T H O D S
2. MATERIALS AND METHODS.
2.1. MATERIALS.
2.1.1. Proteins and Enzymes.
Ricin A chain, ricin B chain and ribonuclease A (from bovine pancreas) 
were supplied by Sigma Chemical Co. Ltd., Dorset, U.K. Ricin B chain was 
also obtained from Xoma Corporation, San Fransisco, U.S.A, and E.Y. 
Laboratories, San Mateo, U.S.A.
2.1.2. Chemicals.
N-succinimidyl-3-(2.-dithiopyridyl) propionate (SPDP),
4-chloro-l-napthol, periodic acid, tris (hydroxymethyl) aminomethane 
(Trizma base), dimethyl sulphoxide were obtained from Sigma Chemical Co. 
Ltd., Dorest, U.K.
Routine reagents, chemicals and solvents were supplied by BDH 
Chemicals Ltd., Dorset, U.K., and were of the highest grade available.
Ribonucleic acid (from yeast) was obtained from Sigma Chemical Co. 
Ltd., Dorset, U.K. Freunds complete and incomplete adjuvant were from 
Difco Laboratories, Detroit, Michigan.
2.1.3. Chromatographic Materials and Equipment.
PD-10 prepacked disposable columns, Sephacryl S-300, Sepharose 4B, 
Polybuffer exchanger PBE 94 and Polybuffer solution PBE 74 were obtained 
from Pharmacia, Uppsala, Sweden. The gel filtration (Superose 12) and the 
ion exchange column (Mono-Q) for the FPLC System were purchased from the 
same source.
2.1.4. Electrophoretic Materials.
Acrylamide, N, N, N* N' tetramethylene diamine (TEMED),
N'N'-methylene bis acrylamide, ammonium persulphate, urea, nonidet P40 
(NP-40) and sodium dodecyl sulphate (SDS) were supplied by BDH Chemicals 
Ltd., Poole, Dorset, U.K. 2-mercaptoethanol was obtained from Koch-Light 
Laboratories, England, U.K. Low molecular weight marker proteins and 
'Pharmalyte' pH 5-8 and pH 3-10 (carrier ampholytes) were supplied by 
Pharmacia Fine Chemicals, Hounslow, Middlesex, U.K.
2.1.5. Stains.
Coomassie blue (G) and napthol blue-black were obtained from Sigma 
Chemical Co. Ltd., Dorset, U.K. Silver nitrate was supplied by Johnson 
Matthey Chemicals, U.K.
2.1.6. Radiochemicals.
35 125
L-( S ]-Methionine, specific activity 1200Ci/mmole, [ I]-iodine
(100 mCi/ml) carrier free were obtained from Amersham International pic,
Amersham, England.
2.1.7. Photographic Materials.
Photographic films, X-ray films (Kodak X-Omat S), DX-80 developer and 
FX-40 X-ray liquid fixer were obtained from Kodak Ltd., Hemel Hampstead, 
U.K.
2.1.8. Serological Reagents.
Goat anti-rabbit IgG (H+L) horse radish peroxidase was supplied by 
Miles Laboratories Ltd., Slough, U.K.
Normal goat serum and normal rabbit serum were obtained from Scottish 
Antibody Production Unit, Wishaw, Scotland, U.K.
Rabbit anti-Ricinus communis lectin was purchased from Sigma Chemical 
Co. Ltd., Dorset, U.K.
2.1.9. Cell Culture Materials.
RPMI-1640, foetal calf serum (FCS) and L-glutamine were obtained from 
Gibco Ltd., Paisley, U.K. Penicillin and streptomycin were supplied by 
Glaxo Pharmaceutical LtcL, London.
2.1.10. Disposable Plasticware.
Tissue culture flasks were supplied by Nunc, Trident House, Paisley, 
U.K. Tissue culture plates (96 wells and 24 wells) were supplied by 
Costar, Northumbria Biologicals Ltd., Northumbria, U.K. Sterile universals 
were obtained from Sterilin Ltd., Feltham, England, U.K.
2.1.11. Cell Line.
The human B lymphoma cell line Daudi (Klein, et.al., 1968) was employed in 
cellular cytotoxicity assays. The line was routinely maintained as a 
suspension culture.
2.1.12. Rabbits.
Male New Zealand Whites.
2.1.13. Miscellaneous Materials.
Eppendorf tubes (1.5ml capacity) were obtained from Anderman and Co., 
Surrey, U.K. Dialysis tubing was supplied by Visking Tubing, Scientific 
Instruments Centre, London. Micropipettes and tips were obtained from 
Gilson Anachem Ltd., Luton, U.K. Multi-channel micropipettes were obtained 
from Flow Laboratories, Ayrshire, U.K.
2.2.. PURIFICATION OF RICIN B CHAIN.
Due to the presence of ricin in the 'purified' ricin B chain 
supplied by E.Y. Laboratories and Sigma Chemical Co. a purification 
procedure had to be developed.
2.2.1. Sample Preparation.
METHOD A.
500ug ricin B chain in 0.1M Tris-HCl, pH 7.2 containing 0.1M lactose
and 0.02% sodium azide was microdialysed against the following buffers 
o
overnight at 4 C:-
a) 0.1M Tris-HCl, pH 7.2
b) PBS, pH 7.2 (170mM NaCl, 3.4mM KC1, lOmM Na^HPO^ , 1.8mM KH^PO^). 
The dialysed sample was then centrifuged in a fixed angle rotor at
10,000 x g for 15 min, before application to the Superose 12 column (gel 
filtration).
METHOD B.
Method A was followed, but after dialysis the sample volume was 
measured and solid ammonium sulphate was added to give a final 
concentration of 60% (w/v) in the solution. The sample was then 
centrifuged in a fixed angle rotor at 10,000 x g for 20 min. The 
supernatant was removed, and the precipitate resuspended in 250ul of 0.1M 
Tris-HCl, pH 7.2. The sample was then dialysed against 0.1M Tris-HCl, pH
7.2 to remove the ammonium sulphate. After dialysis the sample was again 
centrifuged at 10,000 x g for 15 minn before application to the Superose 
12 column.
2.2.2. Gel Filtration (Superose 12).
There are a number of high performance techniques available with 
Pharmacia FPLC (fast protein liquid chromatography) system, including
chromatofocusing, reversed phase, affinity chromatography and ion 
exchange, but gel filtration was the technique selected. Thus, rapid 
results, high resolution, maintenance of biological activity and 
structural integrity of the applied sample could be obtained.
The Pharmacia Superose 12 column (1cm x 30cm packed with a 
cross-linked, agarose-based medium) was used to achieve separation of 
ricin from ricin B chain. The Superose 12 column was equilibrated with 
0.1M Tris-HCl, pH 7.2 (0.22uM filtered).
The 200ul sample was loaded on to the equilibrated column and eluted 
with 0.1M Tris-HCl, pH 7.2 (flow rate lml/min). 0.5ml fractions were 
collected and their absorption profile at 280nm was recorded along with 
the corresponding fraction number by the chart recorder (lcm/ml). When 
the sample had eluted from the column, the equilibration buffer was 
replaced by 24% ethanol (0.22um filtered) under which the column material 
was stored. The fractions corresponding to the peaks were pooled, or 
individual fractions were analysed by SDS-PAGE (Section 2.5. \  The 
polyacrylamide gels were silver stained (Section 2.7.), to determine the 
purity of the ricin B chain.
The Superose 12 column was also equilibrated with PBS, pH 7.2 so 
that this buffer could be used in conjunction with the column to purify 
the ricin B chain.
2.2.3. Chromatofocusing.
The isoelectric point of ricin (pi 7.1) and ricin B chain (pi 4.8) 
are quite different and, therefore, chromatofocusing can be utilised to 
separate these proteins.
Polybuffer exchanger (PBE 94), 10ml, was poured into a sintered 
glass funnel, and the gel was equilibrated with 0.025M histidine-HCl, pH
6.2 (150ml). The equilibrated gel was then packed in the column (10cm x 
lcm).
Ricin B chain, 3mg, was dialysed against 1 litre of 0.025M 
histidine-HCl, pH 6.2 for 4hr. The sample was then applied to the 
column. The column was eluted using degassed polybuffer 74-HC1, pH 4.0 
(1:8 dilution, polybufferrdistilled water), the flow rate was 
approximately 0.5ml/min. 1ml fractions were collected and the absorbance 
at 280nm of each was plotted on a chromatogram. The fractions containing 
the ricin B chain were pooled.
The ricin B chain polypeptide was separated from the polybuffer 
74-HC1 using a Sepharose 4B column (L. Roberts and G. Clements, Warwick 
Uni., personal communication). Sepharose 4B was pre-treated with 1M 
propionic acid for three weeks, this was then poured into a sintered 
glass funnel. The Sepharose 4B was equilibrated with PBS, pH 7.2 and 
then packed in a column (20cm x 1cm). The ricin B chain/polybuffer 
74-HC1 was then applied to the column. PBS, pH 7.2 was used to elute the 
polybuffer from the column, 1ml fractions were collected and the 
absorbance at 254nm of these were recorded to determine when the 
polybuffer had been completely eluted. PBS, pH 7.2 containing 0.1M 
galactose was used to elute the ricin B chain which had bound to the 
Sepharose 4B column. 1ml fractions were again collected and the 
absorbance at 280nm of each was recorded and plotted on a chromatogram.
12.5% SDS-PAGE electrophoresis (Section 2.5.), silver staining 
(Section 2.7.), and toxicity assays (Section 2.13.2J were used to 
determine the purity of the ricin B polypeptide.
2.3. PROTEIN CHEMICAL PROCEDURES.
2.3.1. Perivatisation of Ribonuclease A.
The heterobifunctional cross-linking agent, SPDP, was selected to 
derivatise ribonuclease A such that hybrid proteins linked by a disulphide 
bond could be synthesised.
An assay to determine the concentration of SPDP required for optimal 
derivatisation of ribonuclease A was performed. A stock solution of 2ug/ul 
SPDP in dimethyl sulphoxide (DMSO) was prepared, then the following 
increasing concentrations of SPDP in 20ul DMSO (Oug, lug, 2ug, 5ug and 
lOug) were added to individual eppendorfs containing lmg/ml ribonuclease A 
in PBS, pH 7.2. The samples were incubated for lhr at room temperature, 
then micro-dialysed against PBS, pH 7.2 overnight at 4°C to remove excess 
reagent and DMSO. A Carlsson Assay, (see section 2.3.2.) was carried out 
so that the substitution ratio of moles pyridyl dithiopropionate groups per 
mole ribonuclease A could be determined.
Routinely, to derivatise lOmg/ml ribnonuclease A in PBS, pH 7.2, 50ug 
SPDP in 25ul DMSO was added. The only alteration to the procedure 
described above was that microdialysis was replaced by gel filtration using 
a PD-10 Sephadex G25 column. The absorbance at 280nm of individual 1ml 
fractions was measured and protein-containing fractions pooled. The 
substitution ratio was determined using the Carlsson Assay (See Section
2.3.2.).
2.3.2. Carlsson Assay.
This spectrophotometric assay described by Carlsson, et al., (1978) 
was used to calculate the substitution ratio of pyridyl diothiopropionate 
groups per mole protein.
The absorbance at 280nm (A ) and (A ) of 1ml derivatised
280 343
ribonuclease A was measured and recorded. The substituted ribonuclease A
was then placed in an eppendorf tube and 5ul 2-raercaptoethanol was added
and mixed. The sample was then incubated at 37°C for 30 min. A second
measurement of the absorbance at 343nm (A ') of the sample was then
343
made. The absorbance at 280nm of lmg/ml ribonuclease A (unsubstituted) in
PBS* pH 7.2 was measured and recorded.
The substitution ratio is calculated by dividing the moles of
pyridine-2-thione released by the moles of protein present. The
concentration of pyridine-2-thione released in micromolar terms, [P2T], was
calculated from the difference in absorbance readings at A of the
343
sample according to the equation;
(P2T] - <A„ A„ ) +  0.008.
343 343 0
The true absorbance value of the substituted protein at 280nm (A ' )
280
can be calculated from the reading which was recorded and which includes 
absorption by the dithiopropionate groups, according to the equation;
A280' - A280 " <5- y ‘ 10l * v./
(Note that in this instance the concentration of P2T is expressed in 
molar terms).
To determine the concentration of protein in mg/ml the A • value is 
, e 280
\ i
diyided„by the A2go va*ue unsubstituted ribonuclease A, and this
can then be easily converted to moles protein present.
2.3.3. Synthesis of Ribonuclease A and Ricin B Chain Complex.
Five microlitres of 13M 2-mercaptoethanol was added to 500ul ricin B 
chain (2mg/ml), mixed, and left at room temperature for 30 min. The 
sample was then applied to a PD-10 Sephadex G25 column pre-equilibrated 
with PBS, pH 7.2. The ricin B chain was then eluted from the column using 
PBS, pH 7.2, 1ml fractions being collected. The absorbance at 280nm of the 
fractions were measured and a chromatogram plotted.
To the fraction(s) containing the freshly reduced ricin B chain an 
equal concentration of derivatlsed ribonuclease A, (See Section 2.3.10* was 
added, mixed and allowed to stand for lhr at room temperature. Formation
Figure 2. Bovine Pancreatic Ribonuclease A : Ricin B Complex
Synthesis.
The amino group of lysine residues present in RNase A react 
with the carboxyl group of the cross-linking reagent, SPDP, 
releasing N-hydroxysuccinimide. The derivatised RNase A then 
reacts with the reduced sulphydryl of the ricin B chain, such 
that pyridine-2-thione is released and the hybrid protein is 
formed.
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of the complex was then determined by SDS-PAGE (See Section 2.5.). The 
SDS-PAGE Gels were silver stained (See Section 2.7.) to allow visualisation 
of the complex. (See Figure 2)
2.3.4. Iodination of Proteins.
Proteins were iodinated by the 'Iodogen' method of Fracker and Speck,
(1978). 1, 3, 4, 6 tetrachloro - 3 , 6  diphenylglycouril ('IODOGEN') was
dissolved at lmg/ml in chloroform and 1ml was evaporated on to the walls of
a glass bijoux bottle.
Five hundred microlitres protein (0.5mg/ml) in PBS, pH 7.2 was added
to the iodogen coated bijoux bottle and incubated on ice for 30 min. lOOuCi 
125
of carrier-free ( I] was then added, and following a 30 min. incubation 
on ice the reaction mixture was separated on a PD10 Sephadex G25 column 
equilibrated with PBS, pH 7.2. 1ml fractions were collected, 5ul of each 
being counted in an LKB Wallac '1275 Minigamma' counter. The 
radioiodinated protein peak was pooled and stored in a lead pot at -20°C.
2.3.5 Synthesis of Iodinated Ribonuclease A and Ricin B Chain Complex.
The synthesis of iodinated ribonuclease A and ricin B chain complex 
was carried out exactly as described in Section 2.3.3. Formation of the 
complex was determined by autoradiography of 12.5% SDS-PAGE gels,(see 
Section 2.5. and 2.8.).
2.3.6. Amidination of Ribonuclease A.
The method that was followed for amidination of the ribonuclease A was 
described by Coggins, (1978).
A 20mM dimethylsuberimidate solution in lOOmM buffer (1 vol 200mM 
triethanolamine - HC1, pH 8.5 and 1 vol 40mM sodium hydroxide) was prepared 
and used immediately. The ribonuclease (50uM in lOOmM triethanolamine -
HC1* pH 8.5) was added to an equal volume of the dimethylsuberimldate
o
solution and incubated at 20 C for 2 hr. To remove decompositon products, 
excess reagent and change the buffer present in the amidinated ribonuclease 
A, the sample was applied to a PD-10 Sephadex G25 column equilibrated with 
PBS, pH 7.2 and eluted with the same buffer. 1ml fractions were collected.
The absorbance at 280nm of each of the fractions was measured in an L.K.B. 
spectrophotometer, and the absorbance versus fraction number was plotted on 
a chromatogram, so that the amidinated ribonuclease A fraction could be 
isolated and pooled. The polymerised ribonuclease A was then analysed by 
SDS-PAGE gel electrophoresis, (see section 2.5.) and by ribonuclease A 
activity gel? (see section 2.9.).
2.4. FPLC—MONO Q PURIFICATION OF THE RIBONUCLEASE A-RICIN B COMPLEX.
2.4.1. Sample Preparation.
The sample containing RNAse A-ricin B complex, RNAse A and ricin B 
polypeptide was centrifuged in a fixed angle rotor at 10,000 x g for 15 
min. The supernatant was removed and this was then applied to the 
FPLC-Mono Q column.
2.4.2. Pre-equilibration Of The Column.
Buffer A:- lOmM NqCl in 20mM Tris-HCl, pH 7.0.
Buffer B:- 1M NaCl in 20mM Tris-HCl, pH 7.0.
The FPLC-Mono Q anion exchanger column was pre-equilibrated with the 
buffers according to the protocol from Pharmacia for use in conjunction 
with their columns. The buffer flow rate was set at l.Oml/min and the 
chart recorder was set at 0.5cm/ml to record the equilibration profile. 
Firstly, 5.0ml buffer A was passed over the column, then in 0.1ml the 
buffer was changed to buffer B and 9.9ml of this was passed over the 
column. The buffer was again changed to buffer A in 0.1ml and 4.9ml of 
this buffer was passed over the column.
2.4.3. Purification Of The RNAse A - Ricin B Complex.
The sample (500ul) was applied to the column and the proteins which 
were bound, were eluted by increasing the salt concentration of the buffer.
After the sample had been loaded on the column 2ml buffer A was used to 
elute the column, the gradient was subsequently formed in the following 
way:- a gradual mixing of buffers A and B so that after 18ml the salt 
concentration of the eluting buffer was 0.614M (equivalent to 60% (w/v>), 
at 27ml the salt concentration of the buffer was 1.0M (equivalent-to 
100%(w/v)), 6.0ml of this buffer i.e. B was used to elute the column 0.5ml 
fractions were collected and the absorbance at 280nm of each fraction was 
measured and the gradient profile was recorded by the chart recorder (chart 
speed 0.5; O'/'**!). The fractions were analysed by silver staining SDS-PAGE 
gels (Section 2.5. and 2.7.).
This method was useful, as the sample volume was not restrictive, and 
multiple applications of the 500ul samples could be made to the column, as 
long as the protein concentration of the total sample was between 20-50mg. 
This method therefore enabled purification and concentration of the RNAseA 
- ricin B complex.
2.5. POLYACRYLAMIDE GEL ELECTROPHORESIS (SDS-PAGE).
Polyacrylamide gel electrophoresis was performed using the 
discontinuous tris-glycine buffering system (Laemmli, 1970).
2.5.1. Stock Solutions.
Solution A.
45% (w/v) Acrylamide,
1.2% (w/v) N, N' - methylenebisacrylamide.
The solution was deionised with Amberlite MB-2 ion exchange resin, 
filtered, and stored at 4°C in a dark bottle.
Solution B.
1.5M Tris-HCl, pH 8.8 
0.13% (v/v) TEMED.
The solution was filtered and stored at 4°C.
Solution C.
12% (w/v) sodium dodecyl sulphate (SDS).
o
The solution was filtered and stored at 4 C.
Solution D.
20% (w/v) Ammonium persulphate in H^O.
This solution was prepared immediately prior to use.
Solution E.
0.65m Tris - HC1, pH 6.8.
The solution was filtered and stored at 4°C.
Electrophoresis Buffer.
0.25M Tris 
0.132 M Glycine 
0.2% (w/v) SDS
Non-Reducing Sample Buffer (x5).
0.625M Tris-HCl, pH 6.8 
2% (w/v) SDS 
10%(w/v) Glycerol 
0.001% (w/v) Bromophenol blue
Reducing Sample Buffer (x5).
As for non-reducing loading buffer but with the addition of 5% (v/v) 
2-mercaptoethanol.
2.5.2. Separating Gel Preparation.
12.5%, 10%, and 8.5% polyacrylamide separating gels were prepared from 
the stock solutions as follows:-
Acrylamide Gel 8.5% 10%_____ 12.5%
Solution A 11.33ml 13.33ml 16.66ml
Solution B 15.00ml 15.00ml 15.00ml
Solution C 0.5 ml 0.5 ml 0.5ml
Distilled Water 32.66ml 30.67ml 27.4 ml 
Solution D 0.5 ml 0.5 ml 0.5 ml
The solution was then poured to within 25% of the top of the front 
plate of the casting apparatus. 1ml of butan-2-ol was then used to overlay 
the acrylamide solution. The acrylamide solution was then allowed to 
polymerise.
2.5.3. Stacking Gel Preparation.
The stacking gel was prepared from the stock solutions as follows:-
2.64ml Solution A 
2.40ml Solution E 
0.20ml Solution C 
18.67ml Distilled water 
0.20ml Solution D 
0.024ml TEMED
After polymerisation of the separating gel, the butan-2-ol layer was 
poured off, and the acrylamide surface rinsed with distilled water.
The stacking gel was then poured and allowed to polymerise around a 10 
or 20 well teflon comb.
The final dimensions of the gel were 16.5cm x 14.5cm x 0.15cm., or, if 
"mini-gels" were employed, 8.0cm. x 7.0cm. x 0.05cm.
2.5.4. Electrophoresis Conditions.
Electrophoresis was performed for 3 - 4hr at room temperature at a 
constant current of 40mA per slab gel or overnight (at room temperature) at 
a constant current of 9mA per slab gel.
2.5.5. Molecular Weight Standards.
The low molecular weight standards (Pharmacia) comprise the following 
proteins:-
Protein Mr Source
Phosphorylase b 94,000 Rabbit muscle
Albumin 67,000 Bovine serum
Ovalbumin 43,000 Egg white
Carbonic Anhydrase 30,000 Bovine erythrocyte
Trypsin Inhibitor 20,100 Soybean
-Lactalbumin 14,400 Bovine milk
0.1 ml of non-reducing loading buffer was added to the lyophilised low 
molecular weight standards. The standards were then boiled at 100°C for 3 
minutes. Five microlitre samples of molecular weight standards were loaded 
into the appropriate slots of the gel.
2.5.6. Sample Preparation.
All samples contained between lug - lOug of protein. To each protein 
sample, one-fifth volume of reducing or non-reducing sample buffer was 
added. The samples were then boiled at 100°C for 3 minutes before loading
into the individual wells of the stacking gel.
2.6. COOMASSIE BLUE STAINING.
2.6.1. Coomassie Blue Stain.
0.25% (w/v) Coomassie blue G-250
45% (v/v) ethanol
10% (v/v) glacial acetic acid
2.6.2. ’Destain1 for Coomassie Blue.
45% (v/v) ethanol
10% (v/v) glacial acetic acid
After electrophoresis the gels were stained with Coomassie blue for 
lhr. The gels were then placed in 'destain' to remove the background 
colour and allow examination of the stained protein bands.
2.7. SILVER STAINING.
The silver stain method of Tsai and Frasch (1982) was also used to 
detect protein bands. Double-deionised water was used both in preparation 
of all glassware and throughout the experimental procedure.
2.7.1. Solutions for Silver Stain.
Fixing Solution.
40% (v/v) ethanol
10% (v/v) glacial acteic acid
Oxidising Solution.
0.7% (w/v) periodic acid in fixing solution.
Silver Stain.
28 ml 0.1N sodium hydroxide 
2 ml concentrated ammonia 
5 ml 20% (w/v) silver nitrate 
115 ml water
Developer (200ml).
0.005% (v/v) citric acid 
0.1 ml 37% w/v formaldehyde
Stabilising Solution.
3% (v/v) glacial acetic acid
2.7.2. Experimental Procedure.
After the completion of electrophoresis the gel was placed in the 
fixing solution overnight. The gel was transferred to 100ml oxidising 
solution for 5 min. with shaking, and then washed for 45 min. with at least 
4 changes of water (500ml/wash). After the last wash, the silver stain 
(150ml) was added and the gel incubated at room temperature for 10 min. 
with shaking. The silver stain was removed and the gel washed for 30 min. 
with 4 changes of water (500ml/wash), followed by addition of the developer 
(200ml) until the protein banding pattern of required intensity was 
observed. The developed gel was stabilised by washing with water and then 
adding 200ml of stabilising solution. Before the gel could be dried, 
excess water had to be removed by placing the gel in 45% (v/v) ethanol;
10% (v/v) glacial acetic acid.
2.8. AUTORADIOGRAPHIC PROCEDURES.
2.8.1. Gel Preparation.
The gels were immersed in 45% (v/v) ethanol, 10% (v/v) glacial acetic 
acid for 15 -18hr and then dried under vacuum at 80°C on to Whatman 3 MM 
filter paper. The gel and the X-ray film were then placed in a cassette 
containing a Dupont 'Cronex* intensifier screen, and placed at -70°C for 
the required time.
2.8.2. Development of Autoradiograph.
After exposure the autoradiographic images were visualised by
immersing the film in DX-80 developer for 5 min., rinsing with water, then 
immersing in FX-40 fixer for 1 min. The film was then rinsed with water 
and allowed to air-dry.
2.9. ACTIVITY STAINING FOR RIBONUCLEASE A.
2.9.1. Solutions Required for Gel Activity Staining for Ribonuclease A.
Solution A;- 25% (v/v) isopropanol
0.01M Tris-HCl, pH 7.4
Solution B:- 0.01M Tris-HCl, pH 7.4
Solution C:- 0.1M Tris-HCl, pH 7.4
Toluidine Blue *0* stain:- 0.1% (w/v) toluidine blue 'O'
0.01M Tris-HCl, pH 7.4
All solutions were filtered and stored at room temperature.
2.9.2. Ribonuclease A Activity Gel.
To detect ribonuclease A activity polyacrylamide gels containing yeast
ribonucleic acid, an enzymatic substrate, were utilised. The method is that
described by Blank et al., 1982.
To the 12.5% SDS-polyacrylamide gel mixture, as described for SDS-PAGE
(Section 2.5.2) yeast ribonucleic acid was added to give a final
concentration of 0.5 mg/ml. The gel mixture was then poured into the
casting apparatus and allowed to polymerise around the teflon comb.
To each protein sample, one-fifth volume of non-reducing loading
o
buffer was added. The sample was boiled for 3 min. at 100 C, before being 
loaded. Electrophoresis at a constant current of 50mA for 3hr, was carried 
out at 4°C using pre-cooled tris-glycine buffer (electrophoresis buffer). 
The gel was then washed twice in 400ml of solution A for 30 min. at
room temperature, whilst shaking constantly. Isopropanol was included to 
facilitate the removal of SDS from the gel. The gel was then rinsed with 
400ml of solution B (two changes) for 30 min. Enzymatic digestion of the 
yeast ribonucleic acid contained within the gel matrix occurred when the 
gel was incubated in 400ml solutin C at 37°C for 2hr. Again the gel was 
rinsed with 400ml solution B for 10 rain. The undigested ribonucleic acid 
is stained with the toluidine blue '0* solution for 10 min. at room 
temperature. The gel was placed in 400ml solution B to destain. Solution 
B was replaced daily over a period of 2-3 days. Any clear "plaques" which 
were visualised were the result of ribonuclease A activity.
2.10. IMMUNOBLOTTING.
Proteins transferred on to the nitrocellulose paper were detected 
using enzyme conjugated anti-sera as described by Towbin, et al., (1979).
2.10.1. Immunoblotting Stock Solutions.
Transfer Buffer.
0.025M Tris-HCl,pH 8.6 
0.16M glycine 
20%(v/v) methanol
0.02% (w/v) sodium dodecyl sulphate 
Stain.
0.01% (w/v) napthol blue-black 
10% (v/v) glacial acetic acid 
50% (v/v) methanol
Destain.
10% (v/v) glacial acetic acid 
50% (v/v) methanol
Substrate Stock Solution.
0.3% (w/v) 4-chloro-l-napthol in methanol
Stored in dark bottle at 4°C.
Working Solution.
3ml 4-chloro-l-napthol stock solution
5ml PBS, pH 7.2
0.01% (v/v) hydrogen peroxide
Blocking Buffer.
5% (v/v) normal goat serum in PBS, pH 7.2
Antibody.
Anti-ricin or Anti-RNase A, 1:200 dilution of antibody in blocking 
buffer.
Conjugate.
1:1000 dilution goat anti-rabbit IgG (H+L) horse radish peroxidase in 
blocking buffer.
2.10.2. Experimental Protocol.
Samples were applied as triplicate or quadruplicate sets to 12.5% 
SDS-PAGE polyacrylamide gels (See Section 2.5.). After electrophoresis the 
gel was sectioned. Sponge layers, filter papers and nitrocellulose papers 
were soaked in transfer buffer then layered within the blotting 
cassette(s), ensuring that no air bubbles were present between the gel and 
nitrocellulose paper which would inhibit transfer of protein band(s). The 
cassette was then closed and placed in the transfer tank containing 3 
litres of transfer buffer. The negatively charged protein(s) are then 
transferred to the nitrocellulose paper by means of a constant current of 
350mA for 2.5 - 3hr.
When the transfer was completed one section of nitrocellulose paper
was stained in napthol blue-black for 3 min. and then destained to 
determine whether the proteins had actually transferred.
The remaining sections of nitrocellulose were then incubated in 20ml 
blocking buffer for lhr at room temperature, in order to block any 
remaining sites on the paper. The nitrocellulose was then washed with PBS, 
pH 7.2 (3 buffer changes) for 30 min. at room temperature. The appropriate 
antibody in blocking buffer was added and incubated overnight at 4°C.
The protocol for the PBS, pH 7.2 wash was repeated. The 
nitrocellulose strip was then incubated with goat anti-rabbit IgG (H+L) 
horse radish peroxidase in blocking buffer, for lhr, at room temperature. 
The nitrocellulose was again washed with PBS, pH 7.2 (3 changes) for 30 
min. at room temperature. The addition of the substrate for horse radish 
peroxidase, 4-chloro-1-napthol, present in the working solution, allowed 
visualisation of bands, on the nitrocellulose filter where protein / 
antibody / goat anti-rabbit IgG horse radish peroxidase interactions 
occurred. The nitrocellulose strips were developed at room temperature in 
the working solution until distinctly coloured bands were seen at which 
point the filters were rinsed in deionised water and air dried.
2.10.3. Preparation of Rabbit Anti-Ribonuclease Antiserum.
Primary immunisations were prepared by mixing 0.5ml PBS, pH 7.2 
containing 100-200ug of purified protein with 0.5ml of Freunds complete 
adjuvant (Difco). An emulsion was formed by sonication for 10 seconds at 
probe setting ’low*. The emulsion was injected sub-cutaneously in 3 - 5 
sites on the rabbit's back (0.1 — 0.2 ml per site). Four weeks after the 
initial challenge the rabbit received a booster dose, made using Freunds 
incomplete adjuvant (Difco). Immune serum, denoted RD7, was collected one 
week later by bleeding from the ear and again at intervals following 
subsequent booster injections.
The blood was centrifuged at 1000 x g for 15 min. and the serum was 
removed. This procedure was repeated twice, and the serum removed was 
pooled.
2.11. TWO-DIMENSIONAL GEL ELECTROPHORESIS.
In order to determine the net charge of the protein complexes, two 
dimensional gel electrophoresis was used.
2.11.1. Isoelectric Focusing in the First Dimension.
Gel Solution.
5.5% (w/v) Urea
1.33ml 28.3% (w/v) Acrylamide / 1.62%(v/v) bisacrylamide
2.00ml 10% nonidet P-40
1.95ml de-ionised water
0.40ml Pharmalyte ampholines pH 5-8
0.10ml Pharmalyte ampholines pH 3.5-10
0.10ml 10% (w/v) ammonium persulphate
0.005ml TEMED
Electrophoresis Solutions.
Upper Resevoir.
20mM sodium hydroxide
Lower Resevoir.
lOmM phosphoric acid
Sample Buffer.
9.5M urea 
2.0%(v/v) NP-40
1.6% (v/v) Pharmalyte ampholines pH 5-8 
0.4% (v/v) Pharmalyte ampholines pH 3-10
Overlay Buffer.
50% (v/v) sample buffer in deionised water.
NEPHGE Buffer.
2.3% (w/v) SDS 
10.0% (v/v) glycerol 
0.1% (w/v) bromophenol blue
2.11.2. SDS-PAGE Gel Electrophoresis in the Second Dimension.
10% (w/v) acrylamide resolving gels and 5%(w/v) acrylamide stacking 
gels were employed. The procedures were as described in section 2.5.
2.11.3. Experimental procedure.
Gel tubes ( 12.0 x 0.2cm) with nescofilm enclosing the bottom end, 
were filled to within 1cm of the top with the first dimension gel solution.
The acrylamide solution was then overlaid with deionised water and left to 
polymerise. The deionised water was removed, and replaced with 25ul sample 
buffer for 20 min. as this equilibrated the gels. The sample buffer was
then replaced with a further 25ul of sample buffer and placed in the
electrophoresis tank. Appropriate electrophoresis solutions were then 
placed in the upper and lower reservoirs and the gels pre-run at the 
following voltages, sequentially, 200 volts for 15 min., 300 volts for 30 
min. and 400 volts for 30 min. After this treatment the solution was 
removed from the upper reservoirs and the liquid above the gels carefully 
aspirated. The sample and sample buffer were mixed at a ratio of 1:1 to 
give a total volume of 24ul. The sample was then loaded on to the tube 
gels and overlaid with 25ul of overlay buffer and electrophoresed for a 
total of 7000 volt: ^ ^
The gels were then removed from the tubes and equilibrated for lhr in
NEPHGE buffer. A 10% SDS-PAGE separating gel was prepared, but the 
stacking gel was poured to within 1cm of the upper edge of the front plate 
and overlaid with 1ml of butan-2-ol and allowed to polymerise. The 
butan-2-ol was removed and the gel surface rinsed with deionised water.
The equilibrated tube gel was gently inserted between the gel plates 
ensuring that there were no air-bubbles present between the tube gel and 
the stacking gel. Electrophoresis in the second dimension was carried out 
exactly as for SDS-PAGE (Section 2.5.4.). The second dimension gel was
then autoradiographed (Section 2.8.).
2.12. TISSUE CULTURE PROCEDURES.
2.12.1. Heat Inactivation of Foetal Calf Serum.
Foetal calf serum (FCS) was inactivated by heating at 56°C for 30
o
min. The serum was then stored at -20 C.
2.12.2. Cell Culture Medium.
The composition of RPM1-1640 is shown in Table 2. 10% (v/v) heat
inactivated foetal calf serum was added, and this was termed complete 
RPM1-1640.
2.12.3. Routine Culture.
Daudi cells,as suspension cultures, were grown in complete medium at 
37°C in a 95% air / 5% CO^, humidified incubator. The cells were 
sub-cultured every three to four days.
2.12.4. Cell Counting and Determination of Cell Viability.
To ensure an even dispersal of cells throughout the medium, cells were 
gently pipetted a number of times. An aliquot of cells was then removed 
and counted in the Neubauer haemocytometer.
Cell viability was determined on the basis of the uptake of the dye 
trypan blue by dead cells. A known volume of cells was centrifuged at 500 
x g for 5 min., the supernatant was removed and the cells were resuspended 
in the same volume of 0.2%(w/v) trypan blue in PBS, pH 7.2. The percentage 
cell viability was estimated by counting live and dead cells in the 
haemocytometer according to the following equation:-
Number of live cells
Viability ■   x 100%
Total number of cells
TABLE !2
C O M P O S I T I O N  O F  R P M I ~ 1 6 4 0 ‘M E D I U M
A m i n o  A c i d s m g / l i t r e
L ~ A r g i n i n e  ( f r e e  b a s e l 2 0 0 . 0
L - A s p a r a g i n e  ,• 6 5 . 0
L - A s p a r t i c  A c i d 2 0 . 0
L - C y s t e i n e  C 2 H C 1 ) 6 5 . 0
L - G l u t a m i c  A c i d 2 0 . 0
G l y c i n e 1 0 . 0
L - H i s t i d i n e  ( f r e e  b a s e 1 5 . 0
L - H y d r o x y p r o l i n e 2 0 . 0
L - I s o l e u c i n e  ( a l i o  f r e e ) 5 0 . 0
L - L e u c i n e  ( m e t h i o n i n e  f r e e ) 5 0 . 0
L - L y s i n e  H C 1 4 0 . 0
L - M e t h i o n i n e 1 5 . 0
L - P h e n y l a l a n i n e 1 5 . 0
L - P r o l i n e  ( H y d r o x y - L - P r o l i n e  f r e e ) 2 0 . 0
L - S e r i n e 3 0 . 0
L - T h r e o n i n e  ( a l i o  f r e e ) 2 0 . 0
L - T r y p t o p h a n 5 . 0
L - T y r o s i n e 2 8 . 9 4
L - V a l i n e 2 0 . 0
I n o r g a n i c  S a l t s
C a  ( N 0  ) 4 H  0 1 0 0 . 0
K C 1 4 0 0 . 0
M g S O 4 8 . 8 4
N a C l 6 0 0 0 . 0
N a ^ H P O ^  C a n h y d r o u s ) 8 0 0 . 0
V i t a m i n s
B i o t i n 0 . 2
D - C a l c i u m  P a n t o t h e n a t e 0 . 2 5
C h o l i n e  C h l o r i d e 3 . 0
F o l i c  A c i d 1 . 0
i - I n o s i t o l 3 5 . 0
N i c o t i n a m i d e 1 . 0
P a r a - a m i n o b e n z o i c  a c i d 1 . 0
P y r o d o x i n e  H y d r o c h l o r i d e 1 . 0
R i b o f l a v i n 0 . 2
T h i a m i n e  H y d r o c h l o r i d e 1 . 0
V i t a m i n  B ^ 0 . 0 0 !
O t h e r  C o m p o n e n t s
G l u c o s e 2 0 0 0 . 0
P h e n o l  r e d 5 . 0
R e d u c e d  g l u t a t h i o n e 1 . 0
2 0 0 0  m g / l i t r e  N a H C O ^  w a s  a d d e d  s e p a r a t e l y  t o  d i s s o l v e d  m e d i u m .
T h e  p H  w a s  a d j u s t e d  t o  7 . 0  w i t h  c o n c e n t r a t e d  H C 1 .  T h e  m e d i a  w a s  
s t e r i l i z e d  b y  f i l t r a t i o n  a n d  s t o r e d  a t  4 ° C .
2.13. CELLULAR CYTOTOXICITY ASSAYS.
2.13.1. [3H]-Thymidine Labelling of cells.
Cells were counted and harvested from healthy log phase cultures, by
centrifugation at 500 x g for 5 min. The supernatant was discarded and the
cells resuspended in RPMI-1640 and again centrifuged at 500 x g for 5 min.
This process was repeated once more before finally resuspending the cells
at a concentration of 2.5 x 10^ cells/ml in RPMI-1640. 1 x 105 cells
were added to individual microwells of a ninety-six well plate.
luM stock solutions of ricin, ricin B chain, RNAse A and RNAse A-ricin
B were used to make 1:10 serial dilutions to give a final concentration of
lOnM, InM, O.lnM and O.OlnM in individual, cell-containing microwells. A
set of control wells were also prepared. The final volume in each
microwell was lOOul. The microwell tray was then placed for lhr in a
humidified C0^ incubator at 37°C.
After lhr, the cells contained in the microwell tray were centrifuged
at 500 x g for 10 min. the supernatant was removed and the cells were
resuspended in RPMI-1640. The centrifugation and resuspension of the cells
was repeated three times. After the final centrifugation the cells were
resuspended in complete medium. The cells were then incubated at 37°C for
3
24hr in a humidified CO^ incubator. lOul [ H]-thymidine solution (luCi)
were added to each of the wells and then incubated at 37°C for 4hr.
The cells were then harvested on to a glass fibre filter mat from the
microwell tray using a Flow ‘Titertek* Cell Harvester. After the filter
mat had air dried, the individual discs were removed from the strip, placed
in scintillation vials containing 3ml ecoscint and counted. The percentage 
3
incorporation of [ H]-thymidine into the treated cells compared to the 
control were then calculated and the results shown graphically.
2*13.2. Cells labelled with Methionine.
Cells were counted, harvested and centrifuged at 500 x g for 5 min. 
The supernatant was removed and the cells were resuspended in RPMI-1640 
minus L-methionine. The cells were again centrifuged and resuspended in 
RPMI-1640 minus L-methionine (repeated twice). The cells were finally 
resuspended at a concentration of 2.5 x 10** cells/ml. If the assay to be 
carried out was to determine the purity of the ricin B then the plate was 
laid out in the following way: to four separate wells in each of four rows 
of a twenty-four well costar plate, the following solutions were added (a) 
60ul RPMI-1640 minus L-methionine, (b) 60ul lOOnM - O.lnM ricin solution, 
(c) 60ul lOOnm - O.lnM ricin B chain solution and (d) 60ul lOOnM - O.lnM 
purified ricin B chain, 540ul of cell suspension was added to each of the 
wells, gently mixed and incubated at 37°C for lhr in a humidified CO^ 
incubator.
35After the lhr incubation lOul FCS and lOul of [ S]-methionine
(0.5uCi/ul), were added to each of the wells. The cells were again 
o
incubated at 37 C, whilst at 3hr and 24hr time points, three 50ul samples 
were removed. To each of the samples 20ul ice-cold 60% TCA was added, 
mixed, and left on ice for 20 minutes. The total sample volume was then 
spotted on to 3MM Whatman filter discs and air-dried. The filter discs 
were then given two washes in ice-cold 10% TCA (150ml) over a lhr period. 
The discs were then rinsed in absolute alcohol and allowed to dry.
Individual discs were then placed in scintillation vials containing 
3ml ecoscint and counted for 1 min. in the scintillation counter. The 
resulting counts were used to calculate the percentage inhibition of 
protein synthesis by the toxins compared to the control.
If the toxicity of the RNAse A-ricin B complex was being assayed the 
protocol described was followed exactly but with the inclusion of this 
sample.
2.14. BINDING AND UPTAKE OF IODINATED RIBONUCLEASE A - RICIN B COMPLEX BY
DAUDI CELLS.
2.14.1. Iodinated Samples.
4
Each sample contained 5 x 10 cpm per 50ul. Samples 'a’, 'b', and 
125
' c* contained only [ IJ-ribonuclease A, while samples ' d', 'e', and ' f' 
125
contained [ IJ-ribonuclease - ricin B chain complex. Samples 'a', *b',
' d' and ' e' were prepared in RPMI-1640 and samples 'c' and * f ' were in 
RPMI-1640 containing 0.2M galactose.
2.14.2,, Procedure.
Daudi cells from log phase cultures were counted, harvested, washed
4twice and resuspended at a concentration of 5.0 x 10 cells/ul in 
RPMI-1640.
To sterile, labelled eppendorf tubes containing the iodinated samples
listed above, 2.5 x 10** cells / 50ul were added. The cells were incubated 
o
at 37 C for 2hr, then centrifuged at 500 x g for 5 min. and the 
supernatant discarded. Samples 'a', 'c', 'd* and 'f* were washed five 
times with RPMI-1640, whilst 'b' and 'e' were washed five times with 
RPMI-1640 containing 0.5M galactose. After the fifth wash, all cell 
samples were resuspended in lOOul RPMI-1640 and then transferred to 
counting tubes. The tubes were counted on an LKB Wallac '1275 Minigamma* 
counter. Results were calculated according to the following equation:-
Final cell-associated cpm.
Uptake =*   x 100%.
Input cpm.
and presented as a bar chart.
R E S U L T S  AND DISCU SSION
3. PURIFICATION OF THE RICIN B CHAIN.
3.1. Detection of Ricin in Commercially-purified Ricin B Chain.
SDS-PAGE gel electrophoresis followed by silver staining of the 
protein bands revealed that the ricin B chain obtained from the 
commercial suppliers, E.Y. Laboratories and Sigma Chemical Co. Ltd. 
contained ricin holotoxin (Figure 3). Silver staining was chosen to 
detect the protein bands since both ricin and ricin B are glycoproteins 
and the silver stain was able to detect both the carbohydrate and the 
protein, whilst coomassie blue stains glycoproteins very poorly (Tsai and 
Frasch, 1981). •
Figure 3, track B shows ricin B chain obtained from the Xoma 
Corporation. The low molecular weight band of approximately 30 
kilodaltons is ricin B chain whilst the higher molecular weight band 
corresponds to disulphide-bonded ricin B chain dimers of approximately 60 
kilodaltons. Ricin in track D can be seen to exist as two molecular 
weight forms, 'heavy' (approx. 66 Kd) and 'light' (approx. 64 Kd). The 
'heavy' form is due to the presence of two N-linked oligosaccharides on 
the ricin A polypeptide (therefore termed ricin A^) of the ricin 
molecule, whilst the 'light' form has only one N-linked oligosaccharide 
on the ricin A polypeptide (termed rici.n A^) of the ricin holotoxin 
(Foxwell, et al., 1985). Track C shows ther protein bands visualised by 
silver staining of electrophoretically-separated ricin B chain purified 
by E.Y. Laboratories and Sigma Chemical Co. The electrophoretic 
mobilities of the high molecular weight protein bands correspond 
precisely with those of 'heavy' and 'light' forms of ricin; dimers of 
the ricin B chain are also present.
Due to the presence of ricin in the ricin B chain preparations 
obtained from E.Y. Laboratories and Sigma Chemical Co., procedures for
Figure 3. Detection of Ricin Contamination in 
Commercially-produced Ricin B Chain.
Samples of ricin A chain, ricin B chain (Xoma and E.Y. 
Laboratories) and ricin were analysed by SDS-PAGE on 8.5% (w/v) 
acrylamide gels. After electrophoresis protein bands were 
detected by silver staining.
Tracks:- A - ricin A polypeptide
B - ricin B polypeptide, Xoma
C - ricin B polypeptide, E.Y. Laboratories
D - ricin
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purification of the B chain were developed.
3.2. FPLC - Gel Filtration.
As there is a two-fold difference in the molecular weights of ricin 
and ricin B chain, FPLC-gel filtration appeared to be a suitable system 
for rapid and reproducible purification of the ricin B chain.
Figure 4 shows the result of the initial experiment in which 200ul 
(lug/ul) of protein which had been dialysed against 0.1M Tris-HCl, pH 7.2 
(to remove sodium azide) was applied to the column. The chromatogram 
showed only one protein peak suggesting that there had been no separation 
of ricin B chain from ricin. This was confirmed by SDS-PAGE analysis 
(Figure 4, panel b). As these conditions did not result in the 
separation of ricin from ricin B polypeptide, the buffer was changed to 
PBS, pH 7.2. The resulting chromatogram and SDS-PAGE analysis (results 
not shown) of the fractions wane, indistinguishable from Figure 4. The 
explanation for this is probably the formation of aggregates of ricin and 
ricin B chain in solution. It can be argued that these aggregates are 
the result of either specific or non-specific interactions between the 
ricin B polypeptides and ricin holotoxin leading to the formation of 
complexed proteins. Thus, aggregation of ricin and the ricin B 
polypeptide could be a reflection of complexes which are naturally formed 
within the protein bodies in the endosperm tissue of Ricinus communis for 
the storage of ricin.
To disrupt these protein aggregates, ammonium sulphate was used to 
^ precipitate the proteins from solution. The precipitated proteins were 
then redissolved and dialysed before application to the FPLC-gel 
filtration column. The resulting chromatogram (Figure 5, panel a) showed 
that the sample had been separated into two protein peaks. This was 
consistent with the predicted behaviour of the sample during gel 
filtration since the column is unable to separate the three high
molecular weight input components (i.e. ricin 'heavy* and 'light' forms 
and ricin B dimers) due to the similarity of their molecular weights.
When these protein peaks were analysed by SDS-PAGE (Figure 5, panel b) 
the data showed that the first protein peak (lane A) consisted mainly of 
ricin 'heavy' and 'light' forms, although there were traces of ricin B 
polypeptide present. Lane B showed that there was an extremely low level 
of ricin present in the second peak, and that it consisted mainly of 
ricin B chain.
Denaturing conditions are clearly required for the breakdown of the 
interactions occurring between ricin and ricin B polypeptides. The 
denaturing conditions of SDS-PAGE also leads to the separation of ricin 
and ricin B chain. This suggested, therefore, that it was not an 
inherent property of the ammonium sulphate which led to the separation of 
the two proteins by FPLC-gel filtration.
Although this combined method of precipitation and FPLC-gel 
filtration was leading to purification of the ricin B chain, there were a 
number of factors which detracted from this technique. Firstly, after 
ammonium sulphate precipitation, it proved extremely difficult to 
redissolve the protein precipitate even after dialysis to remove the 
ammonium sulphate, so there was a loss of protein at this initial stage. 
Secondly, the maximum sample volume which could be loaded on the FPLC-gel 
filtration column was 200ul containing a maximum protein load of 5-6mg. 
Therefore, in order to purify a large volume of the protein, multiple 
separations would be necessary, and the separated fractions would require 
to be pooled and concentrated, manoeuvres which would certainly incur 
further protein losses. Thirdly, since the ricin B polypeptide had not 
been purified to homogeneity, at least one more separation by FPLC-gel 
filtration would have been required. This would, again, have led to a 
loss of protein, and a decrease in total yield.
Figure 4. Purification of Ricin B Chain Using FPLC gel 
Filtration.
Panel a. The chromatogram resulting when 200ug unpurified ricin 
B polypeptide was applied to the FPLC-gel filtration column is 
shown. The column was equilibrated with 0.1M Tris-HCl, pH 7.2, 
and the sensitivity of the meter measuring the absorbance was set 
at 0.1.
Panel b. Samples from the three fractions forming the single 
protein peak, were analysed on 12.5% SDS-PAGE gels. The protein 
bands were silver stained. Lanes B, C and D show that all the 
fractions contain ricin, ricin B dimers and ricin B polypeptide.
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Figure 5. Ammonium Sulphate Precipitation and FPLC Gel 
Filtration of Ricin B Chain*
Panel a. The chromatogram showed that ammonium sulphate 
precipitation followed by gel filtration, resulted in separation 
of high molecular weight protein(s) from the lower molecular 
weight protein. The FPLC-Superose 12 column had been 
equilibrated with 0.1M Tris-HCl, pH 7.2 and the sensitivity of 
the meter measuring absorbance at 280nm was set at 0.1.
Panel b. The fractions forming the first protein peak were 
pooled as were the fractions forming the second protein peak. A 
sample was removed from each, and analysed by SDS-PAGE 12.5% 
(w/v) acrylamide. The protein bands were detected by silver 
staining, lane A-peak 1, lane B-peak 2 and lane C-unpurified 
ricin B chain.
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3.3. Chromatofocusing.
Figure 6, panel a* shows the development of the pH gradient in the 
column from pH 6.0 - 4.0 and Figure 6, panel b illustrates the 
profile across the gradient. The first protein peak eluted at a pH of 
approximately 6.0. This peak was expected to contain ricin since the 
isoelectric point of the holotoxin is 7.1. The protein would carry a net 
positive charge at pH 6.0, would not adsorb to the column, and would 
therefore be predicted to elute in the void volume. There was a second 
major peak at approximately pH 4.8 and this would be predicted to contain 
only ricin B chain. Given that the isoelectric point of the ricin B 
chain is 4.8, it would bind to the anion exchanger, and only desorb from - 
the column matrix once the pH of the eluting medium dropped below its pi.
When the fractions from the protein peaks were analysed by SDS-PAGE 
(Figure 7) the data confirmed that ricin B chain had been separated from 
ricin; i.e. there was no minor contamination of either the ricin B 
fractions with ricin holotoxin, or vice versa.
It was interesting that the polybuffer 74, which is an amphoteric 
buffer designed specifically for chromatofocusing in the range pH 7-4 in 
conjunction with the polybuffer exchanger, separated the proteins without 
any prior denaturing treatment. Thus, any aggregates were probably 
dissociated because of the positively charged polybuffer exchanger which 
would strongly repel cations (ricin) from the matrix. This process could 
also have been aided by the ampholyte species present in the polybuffer 
74.
Before the 'purified* B chain could be used experimentally it had to 
be separated from the polybuffer. A gel matrix containing galactose 
binding sites, Sepharose 4B, was selected for this purpose. The ricin B 
polypeptide attached to the column matrix by means of its lectin binding 
sites, whilst the polybuffer passed through the column. The elution of
Figure 6. Chromatofocusing Profiles.
Panel a. The development of an approximately linear pH gradient 
for elution of the chromatofocusing column with polybuffer 94, pH
4.0, is shown.
Panel b. The absorbance at 280nm of each of the fractions is 
shown on the chromatogram. The first peak eluted at a pH of 
approximately 6 and the second peak at a pH of approximately 4.8.
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Figure 7. SDS-PAGE Analysis of Protein Peaks.
Panel a. The fractions forming the protein peaks eluted from the 
chromatofocusing column were analysed by SDS-PAGE. The protein 
bands were detected by silver staining. Lanes B and C, samples 
from fractions constituting peak 1, lanes D to M, samples from 
fractions constituting peak 2.
Panel b. The fractions from the protein peak_:eluted from the 
Sepharose 4B column using PBS, pH 7.2 containing 0.1M galactose 
were analysed by SDS-PAGE 12.5% (w/v) acrylamide. This confirmed 
that the ricin B chain had been purified (lanes B,C and D) from 
ricin (lane A).
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polybuffer from the column was determined by measuring the absorbance at 
254nm since polybuffer absorbs light slightly at this wavelength. The 
ricin B chain was then eluted using PBS, pH 7.2 containing 0.1M
galactose, as the ricin B polypeptide has a greater affinity for the free
galactose than the binding sites of the column matrix. Analysis by 
SDS-PAGE of the fractions from the protein peak from the Sepharose 4B 
column (Figure 7, panel b) confirmed the purity of the ricin B
polypeptide. The binding and desorption of the ricin B chain also
confirmed that the polypeptide had retained its ability to function as a 
lectin.
The yield of purified ricin B polypeptide from the commercial 
preparations varied, but this was mainly due to the differences in the 
level of contamination of the commercial preparations with ricin.
3.4. Toxicity Assay.
35
Incorporation of [ S]-methionine into the neWly-synthesised
proteins of cells in culture is a sensitive assay system for determining
the toxic action of ricin. This assay was therefore used to ascertain
the purity of the ricin B chain which had been separated from holotoxin
contaminants by chromatofocusing.
Figure 8 shows the results of the assay after labelling cellular
35
proteins for 3hr and 24hr with { S ]-methionine, following a lhr
treatment of the cells with the different proteins. Ricin was extremely
toxic to the cells, greatly reducing the level of protein synthesis.
This was most pronounced in the data obtained from the 24hr labelling,
since even the lowest concentration (O.lnM) was exerting a cytotoxic
effect. The titration of toxicity for commercial, unpurified ricin B
chain parallel those obtained for ricin after 3hr and 24hr labelling 
35
periods with { S]-methionine, whilst the ricin B chain purified by the 
techniques described above has little or no effect on protein synthesis
Figure 8. Toxicity of Purified Ricin B Chain to Daudi 
Cells.
o
Daudi cells were incubated at 37 C for lhr with the various
concentrations of ricin, unpurified ricin B chain and 'purified*
ricin B chain indicated on the graphs. Foetal calf serum (10%
35
v/v) and lOuCi [ S] methionine were added to the cells and
incubated at 37°C for 3hr or 24hr before being harvested, TCA
precipitated and counted in the scintillation counter.
35
Panel a. 3hr labelling of the cells with ( S ]-methionine.
Panel b. 24hr labelling of the cells with {35SJ-methionine.
KEY:-
Q  — Ricin
A  — Unpurified Ricin B chain
■  — Purified Ricin B chain
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The variation (approximately plus or minus twenty per cent) is 
attributable to a number of factors including the stage of the cell 
cycle, environmental factors such as pH, temperature, and CO^content of 
the medium.
3.5. Conclusion.
Due to the yields, purity and functional activity of ricin B chain 
obtained after chromatofocusing and affinity chromatography, these 
techniques were utilised for the purification of ricin B chain from the 
commerc ial preparat ions.
The purity of the ricin B polypeptide should be ascertained by 
SDS-PAGE separation followed by silver staining and assays to determine 
its effect on protein synthesis.
4.1. RICIN B CHAIN: POTENTIAL FUNCTIONAL ROLES.
The principal defined biological function of the ricin B 
polypeptide is binding to galactose-containing macromolecules expressed 
at the cell surface. However, it is thought that the ricin B polypeptide 
may also be responsible for facilitating entry of the ricin A chain into 
the cytosol (Youle and Neville 1981, 1982). This project was undertaken 
so that this potential property of the ricin B polypeptide could be 
studied in the context of its ability to effect the transport of other 
proteins across the membraneous elements of cells into the cytosol.
4.2. SELECTION OF THE PROTEIN TO FORM A COMPLEX.
Bovine pancreatic ribonuclease A (Hirs, et al., 1960 and Smyth, et 
al., 1963) was selected as the molecule to be linked to the ricin B
« - «  f  J  ~ ------* 1-----  rr»-1-----    - r ----- J  - - - - - -  
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(a) RNase A is small, having a molecular weight of 13,680 
daltons;
(b) the complete 124 amino acid sequence of the molecule is known;
(c) The protein is extremely stable;
(d) The protein is easily obtained;
(e) The biochemical properties of the RNase A have been determined;
(f) The enzymatic mechanism of action has been elucidated, and no 
cofactors are required. (RNase A catalyses the cleavage of the 
phosphodiester bond between the 3' and 5' positions of the ribose 
moieties in RNA with the formation of oligonucleotides terminating in 
2 ,,3' cyclic phosphate derivatives.);
(g) It had been postulated by others (Obrig, et.al., 1985) that 
the ricin A polypeptide had ribonuclease activity; and
(h) It was possible to assay the enzymatic activity of the RNase A,
when present in a complex with the ricin B chain, both in vivo and in
vitro.
4.3. CONJUGATE SYNTHESIS.
4.3.1. Derivatisation Of Bovine Pancreatic Ribonuclease A.
To enable the in vitro synthesis of a RNase A - ricin B chain 
complex, the heterobifunctional cross-linking reagent, SPDP, was used.
To determine the efficiency of the reaction and the level of substitution
of the RNase A which was required, substitution assays are shown in
Figure 9. The results show that substitution ratios of 0.5 moles pyridyl 
dithiopropionate per mole RNase A were readily achieved using this 
procedure.
RNase A has a well-defined binding cleft for the substrate, in which 
are located residues His-12, His-119, Thr-45 and the side-chains of 
Lys-7, Lys-41 and Lys-66 (Pavlovsky et al.. 1978: ***- gl _ T 1977;
Borkakoti, 1983; Wlodawer et al., 1983). The catalytic activity of the 
enzyme is dependent on the ionizations of the two histidine residues. 
Thr-45 is responsible for the specificity of the enzyme towards 
pyrimidines (i.e. uracil and cytosine), although this is not absolute 
since Ap diester bonds in a polynucleotide are also attacked (Beers, 
1960). The lysine residues, particularly Lys-41, are an important part 
of the catalytic mechanism, for when they are acetylated there is a loss 
of enzymatic activity. The lysine side chains are very mobile in the 
free enzyme, but their mobilities are markedly reduced on the binding of 
the nucleotide substrate. Lys-41 interacts directly with the phosphate 
moiety and is thought to stabilise the pentavalent intermediate in the 
two-step reaction. A low substitution ratio was required when treating 
the RNase A with SPDP as this reagent is lysine-directed. The presence 
of phosphate (a competitive inhibitor of the natural substrate RNA ,
Figure 9. Derivatisation of Ribonuclease A by SPDP.
Seventy nanomoles of RNase A were treated with the indicated 
amounts of SPDP (dissolved in dimethyl sulphoxide) for lhr at 
room temperature. The samples were then dialysed overnight, and 
substitution of PDP groups determined spectrophotometrically 
according to the method of Carlsson, et al., (1978).
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Blackburn and Stanford, 1982) in the buffer will protect Lys-41. Lys-41 
is the only residue that the chemical shift alters on binding of 
phosphate (Brown and Bradbury, 1975; 1976). It was important to
minimise any loss of enzymatic activity, for the assay systems which were
to be used to determine if the complex had been internalised required a 
completely functional enzyme.
4.3.2. Synthesis Of The Hybrid Protein.
Derivatised RNase A (substitution ratio of 0.1 mole pyridyl 
dithiopropionate per mole RNase A (Figure 9) was reacted with
freshly-reduced ricin B chain. The thiol groups of the reduced ricin B
chain effect the elimination of the pyridine-2-thione group from the 
derivatised RNase, yielding a hybrid protein of RNase A - ricin B, linked 
by a disulphide bond, (Section 2.3.3., Figure 2). The formation of the 
complex was determined by separation of the reaction mixture by SDS-PAGE, 
followed by silver staining (Figure 10). Figure 10 !«ne A shewed the
low molecular weight monomers of ricin B chain, approximately 30-33kD, 
and also indicated that ricin B chain dimers were present, approximately 
60kD. Lane D revealed the presence of two high molecular weight bands of 
approximately 28kD (RNase A dimers) and 14kD (RNase A monomers). Lanes B 
and C indicated that a unique band of approximately 45kD was present 
which was in agreement with the values predicted for the apparent Mr of a 
covalent complex of ricin B (30-33kD) and RNase A (14kD). Also present 
in these tracks are the components which were used in the synthesis of 
the hybrid protein (i.e. RNase and ricin B chain).
On comparison of Figure 10 'a' with 10 ' b* it can be seen that the 
level of derivatisation greatly influenced the formation of the complex. 
The derivatised RNase A used to synthesise the complex in Figure 10 1 b' 
had a higher substitution ratio (0.5 mole pyridyl dithiopropionate) 
compared to 0.1 mole pyridyl dithiopropionate used normally for the
Figure 10. Ribonuclease A-Ricin B Complex Formation.
Panel a. The formation of a complex between RNase A and ricin B 
chain was determined initially by SDS-PAGE separation followed by 
silver staining of the protein bands: lane A - ricin B, lanes B 
and C - RNase A-ricin B complex and lane D - derivatised RNase A. 
Panel b. This showed that the level of derivatisation of the 
RNase A has a direct effect on the amount of RNase A-ricin B 
complex formed, lane 2. Lane 1 showed the separation of 
derivatised RNase A and lane 3 ricin B polypeptide.
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synthesis of this complex. As it was necessary to maintain the enzymatic 
activity of the RNase A, then the simplest methods of improving the yield 
were by increasing the amount of both proteins used in its synthesis, or 
by increasing the pH of the disulphide exchange reaction.
It was important to form a disulphide-bonded complex between RNase 
and ricin B, since this imitates the natural bond which is formed between 
the ricin A polypeptide and ricin B polypeptide in vivo. The disulphide 
bond in the native toxin is thought to have a role in the internalisation 
of the toxin and is not simply present to link the two molecules (Section 
1.7.).
4.4. BIOCHEMICAL ANALYSIS OF THE RNase - RICIN B CHAIN HYBRID PROTEIN.
4.4.1. SDS-PAGE Analysis.
A radioiodinated complex was synthesised to facilitate analysis of a 
variety of biochemical and biological properties of the hybrid protein.
In this procedure, RNase A was radioiodinated by the iodogen method prior 
to . synthesis of the RNase A - ricin B chain hybrid. Ricin B chain was 
not iodinated because tyrosine residues have been implicated in the 
ligand binding sites of the ricin B chain, and it was important to 
maintain the functional integrity of this polypeptide (Mise, et al.,
1986; Wawrzynczak, et al., 1987)
The autoradiograph (Figure 11) confirmed the results from the 
silver stained SDS-PAGE gels (see Figure 10). The lane labelled '+2Me' 
contained a sample of the synthesised iodinated complex which had been 
reduced using 2-mercaptoethanol. The reducing agent cleaved the 
disulphide bond which had been formed between the RNase A ricin B such 
that the complex was reduced to its component parts, such that no complex 
band was observed at approximately 45kD. However, the lane labelled ‘-2
Figure 11. Autoradiograph of Iodinated Complex.
The complex was synthesised between iodinated derivatised 
RNase A and ricin B chain. The track labelled '—2 Me' showed 
that a complex had been formed between iodinated derivatised 
RNase A and ricin B chain. Reduction (track '+2 Me*) of the 
complex broke the disulphide bridge, so that the RNase A-ricin B 
complex band was no longer present.
RTB-RNase complex
RNase dimers 
RNase
Me* clearly showed that the complex had been synthesised. Again RNase A 
dimers were present in both tracks, but in the track labelled '+2-Me' the 
band has altered position. This was due to the reducing agent breaking 
the intrachain disulphide bonds <4 in each RNase A monomer) so that the 
molecule unfolds, leading to an alteration in the overall shape of the 
molecule and an apparently slower mobility on SDS-PAGE.
4.4.2. Two-dimensional Gel Electrophoretic Analysis.
The iodinated RNase A - ricin B complex was further analysed using 
two dimensional gel electrophoresis followed by autoradiography. The 
autoradiographs (Figure 12) again confirm that a complex has been formed 
between iodinated RNase A and ricin B chain, for when the complex was 
reduced using 2-mercaptoethanol the band disappeared (Figure 12, panel 
A). Panel B indicated that the RNase A, which has an isoelectric point 
of 9.4 and is therefore a 'basic' protein, has conferred a similar basic 
nature on the RNase A - ifieiii B chain complex. The isoelectric point of 
ricin B is 4.8, so the 'acidic' nature of this polypeptide could have 
influenced the acidic or 'basic' nature of the complex. The isoelectric 
point of the complex is estimated to be in the range pH 8.0 - 8.5.
4.4.3. Immunoblotting Analysis Of The Ribonuclease A - Ricin B Complex.
Immunoblots of the complex, RNase A and ricin B are shown in Figure
13. This was used to confirm that the putative complex, i.e. the 45kD 
band detected by SDS-PAGE analysis, was recognised by both the anti-ricin 
antibody and the anti-RNase antibody, thereby showing that antigenic 
determinants associated with the two proteins used in its synthesis were 
present. Simple protein staining (Figure 13, panel a) did not detect the 
45kD species which was present. Staining of an identical blot with 
antibody RD7 (anti-RNase A) visualised the RNase species and the 45kD 
band (panel c). Development of a blot with an antiserura with specificity
Figure 12. Two-dimensional Gel Electrophoretic Analysis 
of Iodinated Complex.
Iodinated complex (panel b) and reduced iodinated complex 
(panel a) was analysed by two-dimensional gel electrophoresis. 
Isoelectric focusing was performed over the pH range 3.5 - 10, 
and a 10% (w/v) acrylamide gel was employed in the second 
(SDS-PAGE) dimension.
1st dimension
Figure 13. Immunoblots of Ribonuclease A - Ricin B Complex.
Immunoblots of the RNase A-ricin B complex were used to 
determine that the complex did possess antigenic determinants 
which were recognised by anti-ricin antibody (panel 'b') and 
anti-RNase A antibodies (panel 1 c ’). The immunoblot (panel 'a') 
was stained with napthol blue-black to ensure that the proteins 
had transferred. The control using normal rabbit serum in place 
of the antibodies was completely clear (result not shown).
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for ricin components (panel b) stained only ricin B chain monomers and 
dimers, and again recognised the 45kD species. A non-immune serum (not 
shown) failed to bind to any components on the blot. The fact that the 
45kD band is recognised by an anti-RNase A reagent and by a 
ricin-specific antiserum provides strong evidence to support the 
hypothesis that the 45kD band possesses both RNase A and ricin B chain 
components, and is, therefore, a covalent complex of RNase A and ricin B 
chain.
4.5. ASSAY OF BIOLOGICAL ACTIVITY OF THE RNase A - RICIN B CHAIN COMPLEX. 
4.5.1 Polymerised Ribonuclease A.
The protein modification agent dimethyl suberimidate was used to 
prepare cross-linked RNase A. Figure 14 'a' shows the SDS-PAGE profile 
of the resulting cross-linked RNase A preparation; dimers and trimers 
were easily detected by coomassie blue staining of the separated protein 
bands. Dimethyl suberimidate like SPDP is a lysine directed reagent, so 
it was useful to compare the effects of SPDP and dimethyl suberimidate on 
the enzymatic activity of the RNase A.
4.5.2. Ribonuclease Activity Gels.
To determine whether the dimethyl suberimidate-treated RNase A and 
the SPDP cross-linked RNase-A ricin B complex still retained enzymatic 
activity, they were subjected to SDS-PAGE in gels containing yeast RNA 
(Section 2.9.). After electrophoresis the SDS was removed from the gels 
to allow renaturation of the denatured proteins. The gels were then 
incubated at 37°C to allow digestion of the yeast RNA by the RNase A. 
Figures 14 !b ! ana 15 clearly showed the areas of enzymatic digestion 
which were visualised as clear 'plaques' against the background of the 
toluidine blue 'O' stain. Figure 14 'b' , lane A showed that RNase A 
monomers, dimers and trimers retained enzymatic activity, as did the
Figure 14. Polymerised Ribonuclease A.
Panel a. Treatment of RNase A with dimethyl suberimidate 
resulted in the formation of dimers and trimers, which were 
detected by coomassie blue staining of the protein bands after 
SDS-PAGE (12.5% (w/v) acrylamide).
Panel b. Samples of polymerised RNase A were subjected to 
SDS-PAGE on 12.5% (w/v) acrylamide gels containing 0.5mg/ml yeast 
RNA. After electrophoresis, the gels were soaked in isopropanol 
to remove SDS and then stained with toluidine blue. Upon 
destaining, RNase A activity was visualised as clear 'plaques' on 
a blue background. Sample loadings were 2ug polymerised RNase A 
in lane A and lug RNase A in lane B.
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Figure 15. Activity Gel of RNase A - Ricin B Complex.
Samples of RNase A - ricin B complex were subjected to 
SDS-PAGE on 12.5% (w/v) acrylamide gels containing yeast RNA. 
After electrophoresis, the SDS was removed by soaking the gels in 
isopropanol and then the gel was incubated at 37°C for 2hr. The 
areas of enzymatic activity were detected by staining with 
toluidine blue.
Lanes A to D Sample loadings were 10, 8, 4 and 2ug of RNase A -
ricin B complex, respectively.
Lane E Sample loading was 2ug RNase
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monomers and dimers of the untreated RNase A in lane B. Figure 15 showed 
that RNase A present in the complex was enzymatically active (lanes A to 
D), as was the derivatised RNase A used in its synthesis (lane E).
It could be argued that the enzymatic activity observed in Figure 15 
lane E, putatively due to the derivatised RNase A (the highest mobility 
band), was infact due to underivatised RNase A. This could also apply to 
the activity of the RNase A dimers, for in the commercially produced 
RNase A dimers were sometimes present at an extremely low level in the 
preparation. However, the presence of RNase A trimers shown in Figure 14 
1 b ’ and the RNase A-RTB complex (Figure 15) argues against this. These 
results therefore suggest that a low level of substitution of the lysine 
residues does not abrogate the enzymatic activity of RNase, although a 
more significant effect may have been observed if the lysine residue(s) 
at the active site c were involved in the cross-linking. The zymogram 
also showed that RNase A did not require to be released from the ricin B 
chain to be enzymatically active. Thus, the presence of the ricin B 
polypeptide was not causing alterations to the overall three-dimensional 
conformation of the RNase A, which might have resulted in inhibition of 
expression of its enzymatic"activities.
Results (not shown) of a titration experiment to determine the 
lowest concentration of dimethyl suberimidate-treated RNase in which 
enzymatic activity could be detected, suggested a threshold of lOOng.
This was in contrast to the findings of Blank et al., (1981) , who were 
able to detect activity in as little as lOpg of bovine RNase A. However, 
there are a number of factors which could have caused this loss of 
sensitivity, such as the degree of derivatisation of the RNase A, the 
incomplete removal of SDS from the «*»! or center:.inants ir» Lht; SDS which 
can inhibit renaturation of the enzyme (Blank et al., 1981). The 
contaminants in the commercial SDS which may cause this are thought to be 
long chain alkyl sulphates, such as hexa- and / or tetra- decyl sulphate
(Lacks, et al.t 1979) and other impurities, as yet not fully defined. 
Other factors may also affect the rate and efficiency of the renaturation 
of the enzyme and enzyme complexes.
There are two flaws in this technique; namely, the variability of 
the commercially produced SDS which affects the enzymatic activity 
detected, and the uneven background staining of the yeast RNA by the 
toluidine blue *0'. The upper section of the gels in Figure 14 *b* and 
Figure 15 were very weakly stained, due to the slow migration of the 
yeast RNA during electrophoresis, whilst the lower areas of the gels were 
stained very darkly. Therefore, this meant that it was difficult to 
unequivocally detect high molecular weight proteins, such as RNase A 
trimers and RNase A - ricin B complex, by activity staining. The 
uneveness of the staining could be overcome by carrying out the 
electrophoretic separation as for SDS-PAGE (Section 2.5.), then after the 
removal of the SDS incubation of the gel at 37°C in tris buffer 
uouLaiuiug yeast RNA, so that the yeast RNA would intercalate evenly into 
the gel, and the digested yeast RNA would be seen as clear plaques 
against an extremely even background. This technique proved not to be 
applicable in this particular situation (data not shown).
4.6. PURIFICATION OF THE RNase A - RICIN B CHAIN COMPLEX.
Anion exchange chromatography, using the FPLC mono-Q column, was 
chosen as a potential system for the purification of the RNase A - ricin 
B chain complex. From knowledge of the pi values of the components of 
the reaction mixture, it was predicted that the ricin B chain polypeptide 
would bind to the Mono-Q column given its negative charge under the 
conditions of column elution; the RNase A - ricin B chain complex, and 
free RNase A were expected to elute in the void volume. Figure 16, panel 
A, illustrates the elution profile of the reaction mixture; three protein 
peaks are evident.
Aliquots of individual column fractions 1 to 16 were analysed by 
immunoblotting (Figure 16, panels b and c). The immunoblotting analysis 
showed partial purification of the RNase A - ricin B chain complex, since 
fractions 5, 6 and 7 apparently contained only free RNase and the hybrid. 
Further enrichment for the hybrid, by affinity chrOaiato^i apuy on 
propionic acid-treated Sepharose-4B, resulted in significant loss of 
protein, possibly due to aggregation of the material eluted from the 
mono-Q column.
Figure 16. Purification of RNase A - Ricin B Complex 
Using Anion Exchange Chromatography.
Panel a. Chromatogram of the purification of RNase A - ricin B 
complex from the proteins used for its synthesis. The column was 
equilibrated with 20mM tris-HCl, pH 7.0 containing lOmM sodium 
chloride and was eluted with a gradient of sodium chloride (final 
concentration 1M) - gradient profile recorded . The sensitivity 
of the meter for measuring the absorbance of the individual 
fractions was set at 0.2.
One hundred microlitre samples were taken from the 
individual fractions, and acetone precipitated (1 vol:5 vol).
The samples were then loaded on 12.5% (w/v) acrylamide gels and 
then immunoblotted.
Lanes 1 to 16 individual samples corresponding to fractions from 
the chromatogram.
Lane 17 to RNase A - ricin B complex.
Lane 18 to Ricin B polypeptide.
Panel b. Anti-RNase A antibody used in the detection of proteins 
on the immunoblot.
Panel c. Anti-ricin antibody used in the detection of proteins 
on the immunoblot.
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A.7. ANALYSIS OF THE CELLULAR PROPERTIES OF THE RNase A - RICIN B CHAIN
COMPLEX.
4.7.1. Cellular Cytotoxicity Assay.
The toxic action of ricin on cells in culture was readily determined
by observing either its direct effect on protein synthesis by following
the decrease in incorporation of radioactively-labelled methionine into
newly-synthesised proteins, or by monitoring the decrease in the
incorporation of radioactively-labelled thymidine into DNA.
Initially, the 'indirect' or 'long-term* effect of the RNase A -
ricin B complex on the DNA synthesis of cells in culture was
3
investigated. The cells were pulsed for six hours with [ H]-thymidine,
twenty-four hours after the treatment of the cells with the putatively
toxic proteins. Figure 17 showed that derivatised RNase A, ricin B
polypeptide and RNase A - ricin B complex had no effect on the DNA
synthesis of cultured cells, whilst ricin caused complete inhibition of
DNA synthesis at a concentration of lOnM.
The RNase A - ricin B complex may only be exerting an effect on
protein synthesis. To test this hypothesis, the cells were subjected to 
35
pulse with [ S]-methionine for 3 hours and 24 hours after exposure of 
the cells to toxin treatment. Figure 18 panels a and b, again showed that 
ricin was toxic to the Daudi cells, whilst RNase A, ricin B and RNase A - 
ricin B had no detectable effect.
The lack of a cytotoxic effect of the RNase A - ricin B complex on 
DNA or protein synthesis could have resulted from a number of different 
factors including:-
(a) the ricin E polypeptide was unable to bind to the receptors 
present on the cell surface, due to a conformational change on linkage to 
the RNase A;
(b) the inability of the ricin B chain to effect the
Figure 17. Toxicity of RNase A - Ricin B Complex to Daudi cells:
Effect on DNA synthesis.
o
The Daudi cells were incubated for lhr at 37 C with the
various concentrations of the protein solutions in incomplete
medium indicated on the graph. After lhr the cells were washed
then resuspended in complete medium and incubated for 24hr. luCi 
3
[ H)-thymidine was then added to each of the wells and the cells 
incubated at 37°C for a further 4hr. The cells were then 
harvested and the incorporation of radiolabel was determined by 
liquid scintillation spectrophotometry.
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Figure 18. Toxicity of RNase A - Ricin B Complex to Daudi cells:
Effect on Protein Synthesis.
o
The Daudi cells were incubated for lhr at 37 C with the
concentrations of the proteins indicated on the graph. FCS (final
35
concentration 10%) and lOul [ S ]-methionine (5uCi) were added to each
o
well and incubated for 3hr or 24hr, at 37 C. Samples were removed at
the two time points, subjected to TCA precipitation and the incorporation 
35
of [ S]-methionine into the proteins was determined by counting in a 
scintillation counter.
Panel I a. 3hr incubation.
Panel I b. 24hr incubation.
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internalisation of the RNase A - ricin B complex;
(c) the ricin B polypeptide was unable to transport the RNase A
into the cytosol, after the complex had been internalised;
(d) any toxic effect which was expressed by the complex was
transient, so was undetectable in the assay system used;
(e) the concentration of RNase A which was internalised was too low
to illicit a measurable response;
(f) the RNase A was Inhibited by the ribonuclease inhibitors which 
are present within the cell, and which appear to be specific for neutral 
RNases of the pancreatic type since they do not inhibit acid lysosomal 
RNase (Shortman, 1962). The ratio of the inhibitor to neutral RNase 
activity tends to increase in tissues characterised by increased rates of 
RNA synthesis and accumulation. Conversely, tissue in which protein 
synthesis decreases and catabolic activity increases usually express 
lower levels of the inhibitor and elevated neutral RNase activity (Liu, 
et al.. 1975? Kyner * et al -, 1979; Greif and Eich, 1972; MiirLhy and 
McKenzie, 1974; Brewer, et al., 1969; Liu and Matrisian, 1977; Karplus 
and Weaver, 1976). This arguement could therefore apply to the 
individual cell;
(g) bovine pancreatic RNase is an endonuclease , and its known that 
mRNA being translated by the ribosomes form stable complexes, i.e. 
polysomes (Strickberger, 1976), so it was perhaps difficult for the RNase 
A to gain access to the mRNA;
(h) magnesium is required for translation, the local concentration
++
of Mg present in the polysomes may be too high and inhibit RNase A
| |
(inhibited by Mg at a concentration of 0.05mM). Phosphate acts as a 
competitive inhibitor (Blackburn and Stanford, 1982) and heavy metal ions 
also act as inhibitors, the concentration of these ions in the cytosol 
may inhibit the enzymatic activity of the RNase A; and
(i) Proteases within the cell may recognise the 'complex' as being
'foreign* and therefore degrade it. This could occur in the cytoplasm or, 
if the intracellular routing so directed the complex, to the lysosomal 
compartment•
4.7.2. Binding And Internalisation Of Radioiodinated RNase A - Ricin B 
Chain Complex
The RNase A - ricin B complex had no effect on DNA or protein 
synthesis and this could have resulted very simply from the inability of 
the ricin B polypeptide present in the complex to bind to receptors on 
the cell surface, so that the complex was not internalised.
Iodinated, derivatised RNase A was used to form a complex with the 
ricin B chain, and this iodinated complex was then used to study binding 
and internalisation. The formation of iodinated RNase A - ricin B 
complex was determined by autoradiography of SDS-PAGE gels as described 
in Section 2.5. and 2.8. Figure 19 panel a - bar 2 showed that the 
galactose washes did not remove any complex from the cell surface, 
suggesting that all the complex that had been bound was internalised. 
There is, however, a slight possibility that the galactose was for some 
reason unable to effect the removal of the iodinated complex from the 
receptor i.e. alteration of the binding affinity. The presence of 
galactose clearly acted as an inhibitor, Figure 19 panel a - bar 3, the 
iodinated RNase A - ricin B complex binding to the galactose, rather than 
the receptors on the cell surface, so that the percentage counts were 
similar to those obtained for the control percentage counts of the 
iodinated RNase A - PDP (Figure 19 panel b). This therefore provided 
evidence that the ricin B polypeptide present in the complex retained the 
one proven biological tunction associated with it that of lectin binding.
In this experiment it was assumed that the internalised iodinated 
complex would not have an effect on the cells which could be detected.
Figure 19. Binding/Internalisation of Iodinated Proteins.
a. Binding and internalisation of the RNase A - ricin b complex was
studied by synthesising an iodinated RNase A -ricin B complex. Daudi 
cells were incubated at 37°C for 2hr with the iodinated complex, in the 
presence or abstence of 0.1M galactose (a competitive inhibitor). The 
cells were then washed in PBS, pH 7.2 or PBS, pH 7.2 containing 0.5M
galactose. The samples were then counted in a LKB Wallac '1275
Minigamma1 counter.
b. Binding and internalisation of iodinated RNase A. The samples were 
treated exactly as described in *a’.
KEY:-
1 - Control
2 - Cells washed with PBS, pH 7.2 containing 0.5M galactose.
3 - Cells incubated with PBS, pH 7.2 containing 0.1M galactose.
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4.8.CONCLUSION.
The results from the SDS-PAGE analyses, autoradiography and 
immunoblottting clearly showed that a disulphide-bonded complex could be 
formed between the ricin B polypeptide and RNase A, via derivatisation of 
the latter with the cross-linking reagent SPDP. The nuclease activity of 
the derivatised RNase A and the RNase A in the complex was assayed by 
applying samples to activity gels (zymograms). The results indicated 
that the chemical modification of the RNase A by amino-group directed 
derivatisation did not significantly reduce its nuclease activity. The 
zymogram also showed that the disulphide linkage between the RNase A and 
the ricin B polypeptide did not have to be cleaved for the RNase A to be 
functionally active, unlike the, in vivo relationship between ricin A and B 
chains. For the RNase A-ricin B complex to gain efficient access to the 
cytosol, the ricin B polypeptide has to retain the ability to bind to 
galactose-containing molecules present on the cell surface. This was 
established by studying the binding of iodiimted RNase A — ricin B complex, 
to the lymphoblastoid cell-line, Daudi. The results indicated that the 
iodinated complex had indeed bound to the cell surface, but failed to 
determine whether internalisation had subsequently occurred. 
Unfortunately, the DNA and protein synthesis assays, which were used to 
demonstrate that the RNase A had indeed reached its intracellular 
location and was having a measurable effect on the Daudi cells, may well 
have been complicated by a wide range of interfering factors as discussed 
in the Results Section 4.7.1. Thus, it is perhaps not a total surprise 
that the complex appeared to have no biological activity even if it had 
been successfully internalised.
A number of other molecules have been linked to ricin B chain, 
including the toxin gelonin (Goldmacher, et al., 1987), the toxic A chain 
moiety of abrin (Olsnes, et al. 1974b), insulin (Roth, et al.. 1981; 
Hofmann, et al., 1983), and antibody molecules (Vitetta, et al., 1983,
1984). These molecules were attached to the ricin B polypeptide for a 
variety of reasons. Abrin A - ricin B (both 'acidic* peptides) was 
synthesised so that the toxicity of this hybrid molecule and the effects 
of charge could be studied. Antibody-ricin B complexes were prepared to 
be used in conjunction with antibody - ricin A chain immunotoxins, due to 
the finding that the ricin B molecule could potentiate the cytotoxic 
effect of the ricin A chain immunotoxin. The non-specific binding.of the 
ricin B polypeptide had to be nullified and this provided a method of 
targetting the ricin B chain to a specific cell type. Gelonin-ricin B 
complex was utilised in a comparative study on the toxicity of this 
complex, ricin, diptheria toxin and antibody conjugates (ricin A or 
gelonin) to somatic cell mutants of the human B cell-line Namalwa. The 
protein hormone insulin was linked to the ricin B polypeptide via a 
disulphide bond. The binding of this complex to cells which were 
deficient in insulin receptors was studied, and biochemical responses 
which could be attributed to insulin stimulation were measured (Roth, et 
al., 1980; Hofmann, et al., 1983).
Ricin B chain is capable of transporting either abrin A or gelonin 
both isolated from plants into the cytosol where they exert their toxic 
effect, the inhibition of protein synthesis. When the ricin B chain is
attached to a mammalian protein i.e. insulin or RNase A, the only
conclusion that can be drawn is that these complexes can be bound to the
plasma membrane via the ricin B polypeptide.
The experimental approach which would probably yield the greatest 
amount of information on the possibility of using ricin B chain as a 
vector for transporting proteins into the cell is labelling with either 
colloidal gold or hydrogen peroxidase. The RNase A -ricin B complex 
could be labelled, and then the conjugate could be used for 
internalisation studies with monolayer cultures to determine the
compartments involved in the internalisation of the labelled RNase A - 
ricin B complex. The experimental procedures utilised by van Deurs, et 
al., (1986, 1987) could be followed. The electron microscopic analysis 
of serial sections may well provide evidence for the internalisation of a 
labelled RNaseA - ricin B complex. As with all techniques, there are 
associated problems the ligand i.e. colloidal gold or hydrogen peroxidase 
can effect the binding and the internalisation patterns, incorrect 
fixation and poor sectioning can lead to the formation of artefactsT
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